Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Apr. 17, 2015 |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | Intel Corp | |
Entity Central Index Key | 50863 | |
Company Fiscal Year End Date | -14 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | 28-Mar-15 | |
Document Fiscal Year Focus | 2015 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | FALSE | |
Entity Common Stock Shares Outstanding | 4,744 |
Consolidated_Condensed_Stateme
Consolidated Condensed Statements of Income (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Net revenue | $12,781 | $12,764 |
Cost of sales | 5,051 | 5,151 |
Gross margin | 7,730 | 7,613 |
Research and development | 2,995 | 2,846 |
Marketing, general and administrative | 1,953 | 2,047 |
Restructuring and asset impairment charges | 105 | 137 |
Amortization of acquisition-related intangibles | 251 | 287 |
Operating expenses | 5,115 | 5,103 |
Operating income | 2,615 | 2,510 |
Gains (losses) on equity investments, net | 32 | 48 |
Interest and other, net | 26 | 112 |
Income before taxes | 2,673 | 2,670 |
Provision for taxes | 681 | 740 |
Net income | 1,992 | 1,930 |
Basic earnings per share of common stock (in dollars per share) | $0.42 | $0.39 |
Diluted earnings per share of common stock (in dollars per share) | $0.41 | $0.38 |
Cash dividends declared per share of common stock (in dollars per share) | $0.48 | $0.45 |
Weighted average shares of common stock outstanding: | ||
Basic (shares) | 4,741 | 4,974 |
Diluted (shares) | 4,914 | 5,117 |
Operating Expense [Member] | ||
Amortization of acquisition-related intangibles | $62 | $73 |
Consolidated_Condensed_Stateme1
Consolidated Condensed Statements of Comprehensive Income (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Statement of Comprehensive Income [Abstract] | ||
Net income | $1,992 | $1,930 |
Other comprehensive income, net of tax: | ||
Change in net unrealized holding gains (losses) on available-for-sale investments | -342 | -77 |
Change in deferred tax asset valuation allowance | -3 | -2 |
Change in net unrealized holding gains (losses) on derivatives | -89 | 14 |
Change in net prior service (costs) credits | 2 | -42 |
Change in actuarial valuation | 12 | -2 |
Change in net foreign currency translation adjustment | -178 | 22 |
Other comprehensive income (loss) | -598 | -87 |
Total comprehensive income | $1,394 | $1,843 |
Consolidated_Condensed_Balance
Consolidated Condensed Balance Sheets (USD $) | Mar. 28, 2015 | Dec. 27, 2014 |
In Millions, unless otherwise specified | ||
Current assets: | ||
Cash and cash equivalents | $4,244 | $2,561 |
Short-term investments | 1,864 | 2,430 |
Trading assets | 8,010 | 9,063 |
Accounts receivable, net | 3,246 | 4,427 |
Inventories | 4,418 | 4,273 |
Deferred tax assets | 2,048 | 1,958 |
Other current assets | 2,636 | 3,018 |
Total current assets | 26,466 | 27,730 |
Property, plant and equipment, net of accumulated depreciation of $47,990 ($46,471 as of December 27, 2014) | 33,296 | 33,238 |
Marketable equity securities | 6,549 | 7,097 |
Other long-term investments | 1,675 | 2,023 |
Goodwill | 10,766 | 10,861 |
Identified intangible assets, net | 4,211 | 4,446 |
Other long-term assets | 6,603 | 6,561 |
Total assets | 89,566 | 91,956 |
Current liabilities: | ||
Short-term debt | 1,121 | 1,604 |
Accounts payable | 2,775 | 2,748 |
Accrued compensation and benefits | 2,011 | 3,475 |
Accrued advertising | 1,014 | 1,092 |
Deferred income | 2,196 | 2,205 |
Other accrued liabilities | 5,918 | 4,895 |
Total current liabilities | 15,035 | 16,019 |
Long-term debt | 12,112 | 12,107 |
Long-term deferred tax liabilities | 3,462 | 3,775 |
Other long-term liabilities | 3,125 | 3,278 |
Contingencies (Note 19) | ||
Temporary equity | 908 | 912 |
Stockholders’ equity: | ||
Preferred stock | 0 | 0 |
Common stock and capital in excess of par value, 4,742 shares issued and outstanding (4,752 issued and 4,748 outstanding as of December 27, 2014) | 22,395 | 21,781 |
Accumulated other comprehensive income (loss) | 68 | 666 |
Retained earnings | 32,461 | 33,418 |
Total stockholders’ equity | 54,924 | 55,865 |
Total liabilities, temporary equity, and stockholders’ equity | $89,566 | $91,956 |
Consolidated_Condensed_Balance1
Consolidated Condensed Balance Sheets (Parenthetical) (USD $) | Mar. 28, 2015 | Dec. 27, 2014 |
In Millions, unless otherwise specified | ||
Current assets: | ||
Accumulated depreciation | $47,990 | $46,471 |
Stockholders’ equity: | ||
Common stock, shares issued | 4,742 | 4,752 |
Common stock, shares outstanding | 4,742 | 4,748 |
Consolidated_Condensed_Stateme2
Consolidated Condensed Statements of Cash Flows (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Statement of Cash Flows [Abstract] | ||
Cash and cash equivalents, beginning of period | $2,561 | $5,674 |
Cash flows provided by (used for) operating activities: | ||
Net income | 1,992 | 1,930 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation | 1,848 | 1,720 |
Share-based compensation | 368 | 283 |
Restructuring and asset impairment charges | 105 | 137 |
Excess tax benefit from share-based payment arrangements | -22 | -7 |
Amortization of intangibles | 251 | 287 |
(Gains) losses on equity investments, net | -32 | -48 |
Deferred taxes | -171 | -25 |
Changes in assets and liabilities: | ||
Accounts receivable | 1,167 | 78 |
Inventories | -137 | 405 |
Accounts payable | -71 | -95 |
Accrued compensation and benefits | -1,659 | -1,229 |
Income taxes payable and receivable | 221 | 200 |
Other assets and liabilities | 555 | -135 |
Total adjustments | 2,423 | 1,571 |
Net cash provided by operating activities | 4,415 | 3,501 |
Cash flows provided by (used for) investing activities: | ||
Additions to property, plant and equipment | -2,025 | -2,689 |
Acquisitions, net of cash acquired | -57 | -108 |
Purchases of available-for-sale investments | -139 | -2,509 |
Sales of available-for-sale investments | 43 | 174 |
Maturities of available-for-sale investments | 1,079 | 2,913 |
Purchases of trading assets | -2,475 | -3,225 |
Maturities and sales of trading assets | 3,398 | 2,693 |
Investments in non-marketable equity investments | -278 | -144 |
Other investing | 5 | 146 |
Net cash used for investing activities | -449 | -2,749 |
Cash flows provided by (used for) financing activities: | ||
Increase (decrease) in short-term debt, net | -486 | -245 |
Excess tax benefit from share-based payment arrangements | 22 | 7 |
Proceeds from sales of common stock through employee equity incentive plans | 341 | 479 |
Repurchase of common stock | -750 | -545 |
Restricted stock unit withholdings | -51 | -27 |
Payment of dividends to stockholders | -1,137 | -1,119 |
Collateral associated with repurchase of common stock | 325 | 0 |
Decrease in liability due to return of collateral associated with repurchase of common stock | -325 | 0 |
Other financing | -213 | -200 |
Net cash used for financing activities | -2,274 | -1,650 |
Effect of exchange rate fluctuations on cash and cash equivalents | -9 | 1 |
Net increase (decrease) in cash and cash equivalents | 1,683 | -897 |
Cash and cash equivalents, end of period | 4,244 | 4,777 |
Cash paid during the period for: | ||
Income taxes, net of refunds | $596 | $571 |
Basis_of_Presentation
Basis of Presentation | 3 Months Ended |
Mar. 28, 2015 | |
Basis of Presentation [Abstract] | |
Basis of Presentation [Text Block] | Note 1: Basis of Presentation |
We prepared our interim consolidated condensed financial statements that accompany these notes in conformity with U.S. generally accepted accounting principles, consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended December 27, 2014. We have reclassified certain prior period amounts to conform to current period presentation. | |
We have a 52- or 53-week fiscal year that ends on the last Saturday in December. Fiscal year 2016 is a 53-week fiscal year, and the first quarter of 2016 will be a 14-week quarter. | |
We have made estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, but reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 27, 2014. |
Recent_Accounting_Standards
Recent Accounting Standards | 3 Months Ended |
Mar. 28, 2015 | |
Recent Accounting Standards [Abstract] | |
Recent Accounting Standards [Text Block] | Note 2: Recent Accounting Standards |
In May 2014, the Financial Accounting Standards Board issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. As currently issued, the new standard is effective beginning in the first quarter of 2017; early adoption is prohibited. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method nor have we determined the impact of the new standard on our consolidated condensed financial statements. |
Fair_Value
Fair Value | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||
Fair Value [Text Block] | Note 3: Fair Value | ||||||||||||||||||||||||||||||||
Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for cost method investments, cost method loans receivable, equity method investments, grants receivable, and reverse repurchase agreements with original maturities greater than approximately three months. Substantially all of our liabilities are not measured and recorded at fair value. | |||||||||||||||||||||||||||||||||
Fair Value Hierarchy | |||||||||||||||||||||||||||||||||
The three levels of inputs that may be used to measure fair value are as follows: | |||||||||||||||||||||||||||||||||
Level 1. Quoted prices in active markets for identical assets or liabilities. | |||||||||||||||||||||||||||||||||
Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. Level 2 inputs also include non-binding market consensus prices that can be corroborated with observable market data, as well as quoted prices that were adjusted for security-specific restrictions. | |||||||||||||||||||||||||||||||||
Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data. | |||||||||||||||||||||||||||||||||
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis | |||||||||||||||||||||||||||||||||
Assets and liabilities measured and recorded at fair value on a recurring basis at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
28-Mar-15 | 27-Dec-14 | ||||||||||||||||||||||||||||||||
Fair Value Measured and Recorded at Reporting Date Using | Fair Value Measured and Recorded at Reporting Date Using | ||||||||||||||||||||||||||||||||
(In Millions) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||
Corporate debt | $ | — | $ | 742 | $ | — | $ | 742 | $ | — | $ | 48 | $ | — | $ | 48 | |||||||||||||||||
Financial institution instruments | 226 | 2,172 | — | 2,398 | 321 | 1,119 | — | 1,440 | |||||||||||||||||||||||||
Government debt | — | 50 | — | 50 | — | — | — | — | |||||||||||||||||||||||||
Reverse repurchase agreements | — | 238 | — | 238 | — | 268 | — | 268 | |||||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||||||||||
Corporate debt | 262 | 509 | 32 | 803 | 363 | 412 | 31 | 806 | |||||||||||||||||||||||||
Financial institution instruments | 100 | 502 | — | 602 | 149 | 1,050 | — | 1,199 | |||||||||||||||||||||||||
Government debt | 108 | 351 | — | 459 | 252 | 173 | — | 425 | |||||||||||||||||||||||||
Trading assets: | |||||||||||||||||||||||||||||||||
Asset-backed securities | — | 668 | 40 | 708 | — | 766 | 58 | 824 | |||||||||||||||||||||||||
Corporate debt | 1,922 | 576 | — | 2,498 | 2,625 | 339 | — | 2,964 | |||||||||||||||||||||||||
Financial institution instruments | 950 | 615 | — | 1,565 | 1,146 | 613 | — | 1,759 | |||||||||||||||||||||||||
Government debt | 1,077 | 2,162 | — | 3,239 | 1,295 | 2,221 | — | 3,516 | |||||||||||||||||||||||||
Other current assets: | |||||||||||||||||||||||||||||||||
Derivative assets | — | 776 | 2 | 778 | — | 559 | 2 | 561 | |||||||||||||||||||||||||
Loans receivable | — | 332 | — | 332 | — | 505 | — | 505 | |||||||||||||||||||||||||
Marketable equity securities | 6,487 | — | 62 | 6,549 | 7,097 | — | — | 7,097 | |||||||||||||||||||||||||
Other long-term investments: | |||||||||||||||||||||||||||||||||
Asset-backed securities | — | 2 | 4 | 6 | — | 2 | 4 | 6 | |||||||||||||||||||||||||
Corporate debt | 542 | 519 | 13 | 1,074 | 453 | 728 | 13 | 1,194 | |||||||||||||||||||||||||
Financial institution instruments | 197 | 255 | — | 452 | 189 | 319 | — | 508 | |||||||||||||||||||||||||
Government debt | 68 | 75 | — | 143 | 75 | 240 | — | 315 | |||||||||||||||||||||||||
Other long-term assets: | |||||||||||||||||||||||||||||||||
Derivative assets | — | 68 | 16 | 84 | — | 35 | 22 | 57 | |||||||||||||||||||||||||
Loans receivable | — | 316 | — | 316 | — | 216 | — | 216 | |||||||||||||||||||||||||
Total assets measured and recorded at fair value | 11,939 | 10,928 | 169 | 23,036 | 13,965 | 9,613 | 130 | 23,708 | |||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||
Other accrued liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities | — | 596 | 2 | 598 | — | 563 | — | 563 | |||||||||||||||||||||||||
Other long-term liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities | — | 13 | — | 13 | — | 17 | — | 17 | |||||||||||||||||||||||||
Total liabilities measured and recorded at fair value | $ | — | $ | 609 | $ | 2 | $ | 611 | $ | — | $ | 580 | $ | — | $ | 580 | |||||||||||||||||
Government debt includes instruments such as non-U.S. government bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms such as commercial paper, fixed and floating rate bonds, money market fund deposits, and time deposits. | |||||||||||||||||||||||||||||||||
During the first three months of 2015, we transferred corporate debt, government debt, and financial institution instruments of approximately $494 million from Level 1 to Level 2 of the fair value hierarchy and approximately $398 million from Level 2 to Level 1 ($123 million of corporate debt and government debt from Level 1 to Level 2 and $230 million of corporate debt, government debt, and financial institution instruments from Level 2 to Level 1 during the first three months of 2014). A substantial majority of these transfers were based on changes in market activity for the underlying securities. Our policy is to reflect transfers between the fair value hierarchy levels at the beginning of the quarter in which a change in circumstances resulted in the transfer. | |||||||||||||||||||||||||||||||||
Investments in Debt Instruments | |||||||||||||||||||||||||||||||||
Debt instruments reflected in the preceding table include investments such as asset-backed securities, corporate debt, financial institution instruments, government debt, and reverse repurchase agreements classified as cash equivalents. We classify our debt instruments as Level 2 when we use observable market prices for identical securities that are traded in less active markets. When observable market prices for identical securities are not available, we price the debt instruments using our own models, such as a discounted cash flow model, or non-binding market consensus prices based on the proprietary valuation models of pricing providers or brokers. We corroborate non-binding market consensus prices with observable market data using statistical models when observable market data exists, quoted market prices for similar instruments, or pricing models such as a discounted cash flow model. These valuation models incorporate a number of inputs, including non-binding and binding broker quotes; observable market prices for identical or similar instruments; and the internal assumptions of pricing providers or brokers that use observable market inputs and unobservable market inputs that we consider to be not significant. The discounted cash flow model uses observable market inputs, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. All significant inputs are derived from or corroborated with observable market data. | |||||||||||||||||||||||||||||||||
The fair values of debt instruments classified as Level 3 are generally derived from discounted cash flow models, performed either by us or our pricing providers, using inputs that we are unable to corroborate with observable market data. We monitor and review the inputs and results of these valuation models to help ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes. | |||||||||||||||||||||||||||||||||
Fair Value Option for Loans Receivable | |||||||||||||||||||||||||||||||||
We elected the fair value option for loans receivable when the interest rate or currency exchange rate risk was hedged at inception with a related derivative instrument. As of March 28, 2015, the fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency. Loans receivable are classified within other current assets and other long-term assets. Fair value is determined using a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Gains and losses from changes in fair value on the loans receivable and related derivative instruments, as well as interest income, are recorded in interest and other, net. During all periods presented, changes in the fair value of our loans receivable were largely offset by gains or losses on the related derivative instruments, resulting in an insignificant net impact on our consolidated condensed statements of income. Gains and losses attributable to changes in credit risk are determined using observable credit default spreads for the issuer or comparable companies; these gains and losses were insignificant during all periods presented. We did not elect the fair value option for loans receivable when the interest rate or currency exchange rate risk was not hedged at inception with a related derivative instrument. Loans receivable not measured and recorded at fair value are included in the following "Financial Instruments Not Recorded at Fair Value on a Recurring Basis" section. | |||||||||||||||||||||||||||||||||
Assets Measured and Recorded at Fair Value on a Non-Recurring Basis | |||||||||||||||||||||||||||||||||
Our non-marketable equity investments, marketable equity method investments, and non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment is recognized. | |||||||||||||||||||||||||||||||||
Some of our non-marketable equity investments have been measured and recorded at fair value due to events or circumstances that significantly impacted the fair value of those investments, resulting in other-than-temporary impairments. We classified these investments as Level 3 because the valuations used unobservable inputs that were significant to the fair value measurements and required management judgment due to the absence of quoted market prices. Impairments recognized on non-marketable equity investments held as of March 28, 2015, were $38 million during the first three months of 2015 ($38 million during the first three months of 2014 on non-marketable equity investments held as of March 29, 2014). | |||||||||||||||||||||||||||||||||
Financial Instruments Not Recorded at Fair Value on a Recurring Basis | |||||||||||||||||||||||||||||||||
On a quarterly basis, we measure the fair value of our grants receivable, cost method loans receivable, non-marketable cost method investments, reverse repurchase agreements with original maturities greater than approximately three months, and indebtedness carried at amortized cost; however, the assets are recorded at fair value only when an impairment is recognized. The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
28-Mar-15 | |||||||||||||||||||||||||||||||||
(In Millions) | Carrying | Fair Value Measured Using | Fair Value | ||||||||||||||||||||||||||||||
Amount | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||
Grants receivable | $ | 660 | $ | — | $ | 662 | $ | — | $ | 662 | |||||||||||||||||||||||
Loans receivable | $ | 250 | $ | — | $ | 250 | $ | — | $ | 250 | |||||||||||||||||||||||
Non-marketable cost method investments | $ | 1,800 | $ | — | $ | — | $ | 2,690 | $ | 2,690 | |||||||||||||||||||||||
Reverse repurchase agreements | $ | 450 | $ | — | $ | 450 | $ | — | $ | 450 | |||||||||||||||||||||||
Short-term debt | $ | 1,092 | $ | — | $ | 1,734 | $ | — | $ | 1,734 | |||||||||||||||||||||||
Long-term debt | $ | 12,112 | $ | 10,825 | $ | 2,138 | $ | — | $ | 12,963 | |||||||||||||||||||||||
NVIDIA Corporation cross-license agreement liability | $ | 196 | $ | — | $ | 199 | $ | — | $ | 199 | |||||||||||||||||||||||
27-Dec-14 | |||||||||||||||||||||||||||||||||
(In Millions) | Carrying | Fair Value Measured Using | Fair Value | ||||||||||||||||||||||||||||||
Amount | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||
Grants receivable | $ | 676 | $ | — | $ | 679 | $ | — | $ | 679 | |||||||||||||||||||||||
Loans receivable | $ | 250 | $ | — | $ | 250 | $ | — | $ | 250 | |||||||||||||||||||||||
Non-marketable cost method investments | $ | 1,769 | $ | — | $ | — | $ | 2,599 | $ | 2,599 | |||||||||||||||||||||||
Reverse repurchase agreements | $ | 450 | $ | — | $ | 450 | $ | — | $ | 450 | |||||||||||||||||||||||
Short-term debt | $ | 1,588 | $ | — | $ | 2,145 | $ | — | $ | 2,145 | |||||||||||||||||||||||
Long-term debt | $ | 12,107 | $ | 11,467 | $ | 1,309 | $ | — | $ | 12,776 | |||||||||||||||||||||||
NVIDIA Corporation cross-license agreement liability | $ | 395 | $ | — | $ | 399 | $ | — | $ | 399 | |||||||||||||||||||||||
The fair value of our grants receivable is determined using a discounted cash flow model, which discounts future cash flows using an appropriate yield curve. As of March 28, 2015 and December 27, 2014, the carrying amount of our grants receivable was classified within other current assets and other long-term assets, as applicable. | |||||||||||||||||||||||||||||||||
The carrying amount and fair value of loans receivable exclude loans measured and recorded at a fair value of $648 million as of March 28, 2015 ($721 million as of December 27, 2014). The fair value of our loans receivable and reverse repurchase agreements, including those held at fair value, is determined using a discounted cash flow model. All significant inputs in the models are derived from or corroborated with observable market data, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. The credit quality of these assets remains high, with credit ratings of A+/A1 for the majority of our loans receivable and reverse repurchase agreements as of March 28, 2015. | |||||||||||||||||||||||||||||||||
As of March 28, 2015 and December 27, 2014, the unrealized loss position of our non-marketable cost method investments was insignificant. Our non-marketable cost method investments are valued using a qualitative and quantitative analysis of events or circumstances that impact the fair value of the investment. Qualitative analysis of our investments involves understanding our investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects; the technological feasibility of our investee’s products and technologies; the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes; and the management and governance structure of the investee. Quantitative assessments of the fair value of our investments are developed using the market and income approaches. The market approach includes the use of financial metrics and ratios of comparable public companies, such as revenue, earnings, comparable performance multiples, recent financing rounds, the terms of the investees’ issued interests, and the level of marketability of the investments. The selection of comparable companies requires management judgment and is based on a number of factors, including comparable companies’ sizes, growth rates, industries, and development stages. The income approach includes the use of a discounted cash flow model, which requires significant estimates regarding investees’ revenue, costs, and discount rates based on the risk profile of comparable companies. Estimates of revenue and costs are developed using available market, historical, and forecast data. | |||||||||||||||||||||||||||||||||
The carrying amount and fair value of short-term debt exclude drafts payable. Our short-term debt recognized at amortized cost includes our 2009 junior subordinated convertible debentures due 2039 (2009 debentures). During the first quarter of 2015, the 2009 debentures were classified as short-term debt on the consolidated condensed balance sheets and convertible at the option of the holder during the second quarter of 2015. For further information, see the "Borrowings" note in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 27, 2014. Our long-term debt recognized at amortized cost is comprised of our senior notes and our convertible debentures. The fair value of most of our senior notes is determined using quoted prices in active markets, and is therefore classified as Level 1. The remaining senior notes are classified as level 2 due to quoted prices obtained from less active markets. The fair value of our 2009 and 2005 convertible debentures is determined using discounted cash flow models with observable market inputs, and takes into consideration variables such as interest rate changes, comparable instruments, subordination discount, and credit-rating changes, and is therefore classified as Level 2. | |||||||||||||||||||||||||||||||||
The NVIDIA Corporation (NVIDIA) cross-license agreement liability in the preceding table was incurred as a result of entering into a long-term patent cross-license agreement with NVIDIA in January 2011, pursuant to which we agreed to make payments to NVIDIA over six years. As of March 28, 2015 the carrying amount of the liability arising from the agreement was classified within other accrued liabilities based on the expected timing of the underlying payments ($200 million in January 2016 treated as cash used for financing activities). As of December 27, 2014, the carrying amount of the liability arising from the agreement was classified within other accrued liabilities and other long-term liabilities, based on the expected timing of the underlying payments ($200 million in each of January 2015 and 2016 treated as cash used for financing activities). The fair value is determined using a discounted cash flow model, which discounts future cash flows using our incremental borrowing rates. |
Cash_and_Investments
Cash and Investments | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||||||
Investments and Cash [Abstract] | |||||||||||||||||||||||||||||||||
Cash and Investments [Text Block] | Note 4: Cash and Investments | ||||||||||||||||||||||||||||||||
Cash and investments at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 28, | Dec 27, | |||||||||||||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||||||||||||||
Available-for-sale investments | $ | 13,278 | $ | 13,038 | |||||||||||||||||||||||||||||
Cash | 816 | 805 | |||||||||||||||||||||||||||||||
Equity method investments | 1,574 | 1,446 | |||||||||||||||||||||||||||||||
Loans receivable | 898 | 971 | |||||||||||||||||||||||||||||||
Non-marketable cost method investments | 1,800 | 1,769 | |||||||||||||||||||||||||||||||
Reverse repurchase agreements | 688 | 718 | |||||||||||||||||||||||||||||||
Trading assets | 8,010 | 9,063 | |||||||||||||||||||||||||||||||
Total cash and investments | $ | 27,064 | $ | 27,810 | |||||||||||||||||||||||||||||
Available-for-Sale Investments | |||||||||||||||||||||||||||||||||
Available-for-sale investments at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
28-Mar-15 | 27-Dec-14 | ||||||||||||||||||||||||||||||||
(In Millions) | Adjusted Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Adjusted Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||||||||||||||
Asset-backed securities | $ | 8 | $ | — | $ | (2 | ) | $ | 6 | $ | 8 | $ | — | $ | (2 | ) | $ | 6 | |||||||||||||||
Corporate debt | 2,609 | 15 | (5 | ) | 2,619 | 2,040 | 13 | (5 | ) | 2,048 | |||||||||||||||||||||||
Financial institution instruments | 3,452 | 1 | (1 | ) | 3,452 | 3,146 | 2 | (1 | ) | 3,147 | |||||||||||||||||||||||
Government debt | 651 | 1 | — | 652 | 741 | — | (1 | ) | 740 | ||||||||||||||||||||||||
Marketable equity securities | 3,300 | 3,255 | (6 | ) | 6,549 | 3,318 | 3,779 | — | 7,097 | ||||||||||||||||||||||||
Total available-for-sale investments | $ | 10,020 | $ | 3,272 | $ | (14 | ) | $ | 13,278 | $ | 9,253 | $ | 3,794 | $ | (9 | ) | $ | 13,038 | |||||||||||||||
Government debt includes instruments such as non-U.S. government bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms such as commercial paper, fixed and floating rate bonds, money market fund deposits, and time deposits. Substantially all time deposits were issued by institutions outside the U.S. as of March 28, 2015 and December 27, 2014. | |||||||||||||||||||||||||||||||||
For information on the unrealized holding gains (losses) on available-for-sale investments reclassified out of accumulated other comprehensive income (loss) into the consolidated condensed statements of income, see "Note 18: Other Comprehensive Income (Loss)." | |||||||||||||||||||||||||||||||||
During the first three months of 2015, we sold available-for-sale investments for proceeds of $43 million, none of which was related to sales of cash and cash equivalents ($279 million in the first three months of 2014 of which $105 million related to sales of cash and cash equivalents). The gross realized gains on sales of available-for-sale investments were $43 million in the first three months of 2015 ($67 million in the first three months of 2014). | |||||||||||||||||||||||||||||||||
The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of March 28, 2015, were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Cost | Fair Value | |||||||||||||||||||||||||||||||
Due in 1 year or less | $ | 4,697 | $ | 4,707 | |||||||||||||||||||||||||||||
Due in 1–2 years | 864 | 865 | |||||||||||||||||||||||||||||||
Due in 2–5 years | 779 | 778 | |||||||||||||||||||||||||||||||
Instruments not due at a single maturity date | 380 | 379 | |||||||||||||||||||||||||||||||
Total | $ | 6,720 | $ | 6,729 | |||||||||||||||||||||||||||||
Equity Method Investments | |||||||||||||||||||||||||||||||||
IM Flash Technologies, LLC | |||||||||||||||||||||||||||||||||
Micron Technology, Inc. (Micron) and Intel formed IM Flash Technologies, LLC (IMFT) in 2006 to manufacture NAND flash memory products for Micron and Intel. During 2012, we amended the operating agreement for IMFT and entered into agreements with Micron that modified our joint venture relationship. | |||||||||||||||||||||||||||||||||
The amended operating agreement extended the term of IMFT to 2024, unless earlier terminated under certain terms and conditions, and provides that IMFT may manufacture certain emerging memory technologies in addition to NAND flash memory. The amended agreement provides for certain buy-sell rights. Intel has the ability to cause Micron to buy our interest in IMFT. If we exercise this put right, Micron would set the closing date of the transaction within two years following such election and could elect to receive financing from us for one to two years. Subsequent to our put right, and commencing in January 2018, Micron has the right to call our interest in IMFT with the closing date to be effective within one year. Additionally, our agreements with Micron include a supply agreement for Micron to supply us with NAND flash memory products. These agreements also extend and expand our NAND joint development program with Micron to include emerging memory technologies. | |||||||||||||||||||||||||||||||||
As of March 28, 2015, we own a 49% interest in IMFT. The carrying value of our investment was $786 million as of March 28, 2015 ($713 million as of December 27, 2014) and is classified within other long-term assets. | |||||||||||||||||||||||||||||||||
IMFT is a variable interest entity. All costs of the IMFT joint venture will be passed on to Micron and Intel pursuant to our purchase agreements. Intel's portion of IMFT costs, primarily related to product purchases and production-related services, was approximately $95 million in the first three months of 2015 (approximately $105 million in the first three months of 2014). The amount due to IMFT for product purchases and services provided was approximately $20 million as of March 28, 2015 (approximately $60 million as of December 27, 2014). | |||||||||||||||||||||||||||||||||
IMFT depends on Micron and Intel for any additional cash needs. Our known maximum exposure to loss approximated the carrying value of our investment balance in IMFT, which was $786 million as of March 28, 2015. Except for the amount due to IMFT for product purchases and services, we did not have any additional liabilities recognized on our consolidated condensed balance sheets in connection with our interests in this joint venture as of March 28, 2015. Our potential future losses could be higher than the carrying amount of our investment, as Intel and Micron are liable for other future operating costs or obligations of IMFT. Future cash calls could also increase our investment balance and the related exposure to loss. In addition, because we are currently committed to purchasing 49% of IMFT’s production output and production-related services, we may be required to purchase products at a cost in excess of realizable value. | |||||||||||||||||||||||||||||||||
We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity and, therefore, we account for our interest in IMFT using the equity method of accounting. | |||||||||||||||||||||||||||||||||
Cloudera, Inc. | |||||||||||||||||||||||||||||||||
During 2014, we invested in Cloudera, Inc. (Cloudera). Our fully-diluted ownership interest in Cloudera is 17% as of March 28, 2015. Our investment is accounted for under the equity and cost methods of accounting based on the rights associated with different securities we own, and is classified within other long-term assets. The carrying value of our equity method investment was $278 million and of our cost method investment was $454 million as of March 28, 2015 ($280 million for our equity method investment and $454 million for our cost method investment as of December 27, 2014). | |||||||||||||||||||||||||||||||||
Trading Assets | |||||||||||||||||||||||||||||||||
As of March 28, 2015 and December 27, 2014, substantially all of our trading assets were marketable debt instruments. Net losses related to trading assets still held at the reporting date were $200 million in the first three months of 2015 (net gains of $79 million in the first three months of 2014). Net gains on the related derivatives were $194 million in the first three months of 2015 (net losses of $82 million in the first three months of 2014). |
Inventories
Inventories | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Inventory, Net [Abstract] | |||||||||
Inventories [Text Block] | Note 5: Inventories | ||||||||
We compute inventory cost on a first-in, first-out basis. Costs incurred to manufacture our products are included in the valuation of inventory beginning in the quarter in which a product meets the technical criteria to qualify for sale to customers. Prior to qualification for sale, costs that do not meet the criteria for research and development (R&D) are included in cost of sales in the period incurred. Inventories at the end of each period were as follows: | |||||||||
(In Millions) | Mar 28, | Dec 27, | |||||||
2015 | 2014 | ||||||||
Raw materials | $ | 528 | $ | 462 | |||||
Work in process | 2,190 | 2,375 | |||||||
Finished goods | 1,700 | 1,436 | |||||||
Total inventories | $ | 4,418 | $ | 4,273 | |||||
Derivative_Financial_Instrumen
Derivative Financial Instruments | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||
Derivative Financial Instruments [Text Block] | Note 6: Derivative Financial Instruments | ||||||||||||||||||||||||||||||||
Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. When possible, we enter into master netting arrangements with counterparties to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. Generally, our master netting agreements allow for net settlement in case of certain triggering events such as bankruptcy or default of one of the counterparties to the transaction. We may also elect to exchange cash collateral with certain of our counterparties on a regular basis. For presentation on our consolidated condensed balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. Our derivative financial instruments are recorded at fair value and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities. | |||||||||||||||||||||||||||||||||
Currency Exchange Rate Risk | |||||||||||||||||||||||||||||||||
We are exposed to currency exchange rate risk, and generally hedge our exposures with currency forward contracts, currency interest rate swaps, or currency options. Substantially all of our revenue is transacted in U.S. dollars. However, a significant amount of our operating expenditures and capital purchases is incurred in or exposed to other currencies, primarily the euro, the Japanese yen, the Chinese yuan and the Israeli shekel. We have established balance sheet and forecasted transaction currency risk management programs to protect against fluctuations in the fair value and the volatility of the functional currency equivalent of future cash flows caused by changes in exchange rates. Our non-U.S.-dollar-denominated investments in debt instruments and loans receivable are generally hedged with offsetting currency forward contracts or currency interest rate swaps. We may also hedge currency risk arising from funding foreign currency denominated forecasted investments. These programs reduce, but do not eliminate, the impact of currency exchange movements. | |||||||||||||||||||||||||||||||||
Our currency risk management programs include: | |||||||||||||||||||||||||||||||||
• | Currency derivatives with cash flow hedge accounting designation that utilize currency forward contracts and currency options to hedge exposures to the variability in the U.S.-dollar equivalent of anticipated non-U.S.-dollar-denominated cash flows. These instruments generally mature within 12 months. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated condensed statements of income as the impact of the hedged transaction. | ||||||||||||||||||||||||||||||||
• | Currency derivatives without hedge accounting designation that utilize currency forward contracts or currency interest rate swaps to economically hedge the functional currency equivalent cash flows of recognized monetary assets and liabilities, non-U.S.-dollar-denominated debt instruments classified as trading assets, and hedges of non-U.S.-dollar-denominated loans receivable are recognized at fair value. The substantial majority of these instruments mature within 12 months. Changes in the functional currency equivalent cash flows of the underlying assets and liabilities are approximately offset by the changes in the fair value of the related derivatives. We record net gains or losses in the line item on the consolidated condensed statements of income most closely associated with the related exposures, primarily in interest and other, net, except for equity-related gains or losses, which we primarily record in gains (losses) on equity investments, net. | ||||||||||||||||||||||||||||||||
Interest Rate Risk | |||||||||||||||||||||||||||||||||
Our primary objective for holding investments in debt instruments is to preserve principal while maximizing yields. We generally swap the returns on our investments in fixed-rate debt instruments with remaining maturities longer than six months into U.S. dollar three-month LIBOR-based returns, unless management specifically approves otherwise. These swaps are settled at various interest payment times involving cash payments at each interest and principal payment date, with the majority of the contracts having quarterly payments. | |||||||||||||||||||||||||||||||||
Our interest rate risk management programs include: | |||||||||||||||||||||||||||||||||
• | Interest rate derivatives with cash flow hedge accounting designation that utilize interest rate swap agreements to modify the interest characteristics of debt instruments. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated condensed statements of income as the impact of the hedged transaction. | ||||||||||||||||||||||||||||||||
• | Interest rate derivatives without hedge accounting designation that utilize interest rate swaps and currency interest rate swaps in economic hedging transactions, including hedges of non-U.S.-dollar-denominated debt instruments classified as trading assets and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. Floating interest rates on the swaps generally reset on a quarterly basis. Changes in fair value of the debt instruments classified as trading assets and loans receivable recognized at fair value are generally offset by changes in the fair value of the related derivatives, both of which are recorded in interest and other, net. | ||||||||||||||||||||||||||||||||
Equity Market Risk | |||||||||||||||||||||||||||||||||
Our investments include marketable equity securities and equity derivative instruments. We typically do not attempt to reduce or eliminate our equity market exposure through hedging activities at the inception of our investments. Before we enter into hedge arrangements, we evaluate legal, market, and economic factors, as well as the expected timing of disposal to determine whether hedging is appropriate. Our equity market risk management program may include equity derivatives with or without hedge accounting designation that utilize warrants, equity options, or other equity derivatives. We recognize changes in the fair value of such derivatives in gains (losses) on equity investments, net. We also utilize total return swaps to offset changes in liabilities related to the equity market risks of certain deferred compensation arrangements. Gains and losses from changes in fair value of these total return swaps are generally offset by the losses and gains on the related liabilities, both of which are recorded in cost of sales and operating expenses. | |||||||||||||||||||||||||||||||||
Volume of Derivative Activity | |||||||||||||||||||||||||||||||||
Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 28, | Dec 27, | Mar 29, | ||||||||||||||||||||||||||||||
2015 | 2014 | 2014 | |||||||||||||||||||||||||||||||
Currency forwards | $ | 16,192 | $ | 15,578 | $ | 11,729 | |||||||||||||||||||||||||||
Currency interest rate swaps | 5,094 | 5,446 | 4,795 | ||||||||||||||||||||||||||||||
Embedded debt derivatives | 3,600 | 3,600 | 3,600 | ||||||||||||||||||||||||||||||
Interest rate swaps | 1,128 | 1,347 | 1,311 | ||||||||||||||||||||||||||||||
Total return swaps | 1,106 | 1,056 | 989 | ||||||||||||||||||||||||||||||
Other | 72 | 49 | 60 | ||||||||||||||||||||||||||||||
Total | $ | 27,192 | $ | 27,076 | $ | 22,484 | |||||||||||||||||||||||||||
The gross notional amounts for currency forwards and currency interest rate swaps (presented by currency) at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 28, | Dec 27, | Mar 29, | ||||||||||||||||||||||||||||||
2015 | 2014 | 2014 | |||||||||||||||||||||||||||||||
British pound sterling | $ | 314 | $ | 410 | $ | 487 | |||||||||||||||||||||||||||
Chinese yuan | 4,079 | 3,097 | 1,291 | ||||||||||||||||||||||||||||||
Euro | 7,332 | 7,486 | 6,199 | ||||||||||||||||||||||||||||||
Indian rupee | 420 | 418 | 252 | ||||||||||||||||||||||||||||||
Israeli shekel | 2,010 | 2,489 | 1,878 | ||||||||||||||||||||||||||||||
Japanese yen | 4,206 | 3,779 | 3,542 | ||||||||||||||||||||||||||||||
Malaysian ringgit | 827 | 902 | 524 | ||||||||||||||||||||||||||||||
Swiss franc | 1,146 | 1,289 | 1,256 | ||||||||||||||||||||||||||||||
Other | 952 | 1,154 | 1,095 | ||||||||||||||||||||||||||||||
Total | $ | 21,286 | $ | 21,024 | $ | 16,524 | |||||||||||||||||||||||||||
During 2014, we entered into a series of agreements with Tsinghua Unigroup Ltd. (Tsinghua Unigroup), an operating subsidiary of Tsinghua Holdings Co. Ltd., to, among other things, jointly develop Intel® architecture- and communications-based solutions for smartphones. Subject to regulatory approvals and other closing conditions, we have also agreed to invest up to 9.0 billion of Chinese yuan (approximately $1.5 billion as of the date of the agreement) for a minority stake of approximately 20% of the holding company under Tsinghua Unigroup. During the fourth quarter of 2014, we entered into $1.5 billion of forward contracts to hedge our anticipated equity funding of the Tsinghua Unigroup investment. The hedges were designated as cash flow hedges and the related gains and losses attributable to changes in the spot rates will be recognized in accumulated other comprehensive income (loss) until the Tsinghua Unigroup shares are either disposed of or impaired. As the shares are either disposed of or impaired, we will reclassify the gains or losses from accumulated other comprehensive income (loss) to gains (losses) on equity investments, net as an offset to the gain or loss recognized for the share disposal or impairment. Hedge gains and losses attributable to changes in the forward rates will be recognized in interest and other, net. | |||||||||||||||||||||||||||||||||
Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets | |||||||||||||||||||||||||||||||||
The fair value of our derivative instruments at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
March 28, 2015 | December 27, 2014 | ||||||||||||||||||||||||||||||||
(In Millions) | Other | Other | Other | Other | Other | Other | Other | Other | |||||||||||||||||||||||||
Current | Long-Term | Accrued | Long-Term | Current | Long-Term | Accrued | Long-Term | ||||||||||||||||||||||||||
Assets | Assets | Liabilities | Liabilities | Assets | Assets | Liabilities | Liabilities | ||||||||||||||||||||||||||
Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||||||
Currency forwards | $ | 12 | $ | 3 | $ | 483 | $ | 5 | $ | 6 | $ | 1 | $ | 497 | $ | 9 | |||||||||||||||||
Total derivatives designated as hedging instruments | 12 | 3 | 483 | 5 | 6 | 1 | 497 | 9 | |||||||||||||||||||||||||
Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||
Currency forwards | 253 | — | 87 | — | 207 | — | 44 | — | |||||||||||||||||||||||||
Currency interest rate swaps | 510 | 65 | 12 | — | 344 | 34 | 7 | — | |||||||||||||||||||||||||
Embedded debt derivatives | — | — | 1 | 8 | — | — | 4 | 8 | |||||||||||||||||||||||||
Interest rate swaps | 1 | — | 13 | — | 3 | — | 11 | — | |||||||||||||||||||||||||
Other | 2 | 16 | 2 | — | 1 | 22 | — | — | |||||||||||||||||||||||||
Total derivatives not designated as hedging instruments | 766 | 81 | 115 | 8 | 555 | 56 | 66 | 8 | |||||||||||||||||||||||||
Total derivatives | $ | 778 | $ | 84 | $ | 598 | $ | 13 | $ | 561 | $ | 57 | $ | 563 | $ | 17 | |||||||||||||||||
Amounts Offset in the Consolidated Condensed Balance Sheets | |||||||||||||||||||||||||||||||||
The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties and cash and non-cash collateral posted under such agreements at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
28-Mar-15 | |||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Balance Sheet | |||||||||||||||||||||||||||||||||
(In Millions) | Gross Amounts Recognized | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in the Balance Sheet | Financial Instruments | Cash and Non-Cash Collateral Received or Pledged | Net Amount | |||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Derivative assets subject to master netting arrangements | $ | 818 | $ | — | $ | 818 | $ | (465 | ) | $ | (231 | ) | $ | 122 | |||||||||||||||||||
Reverse repurchase agreements | 688 | — | 688 | — | (688 | ) | — | ||||||||||||||||||||||||||
Total assets | $ | 1,506 | $ | — | $ | 1,506 | $ | (465 | ) | $ | (919 | ) | $ | 122 | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities subject to master netting arrangements | $ | 585 | $ | — | $ | 585 | $ | (465 | ) | $ | (49 | ) | $ | 71 | |||||||||||||||||||
Total liabilities | $ | 585 | $ | — | $ | 585 | $ | (465 | ) | $ | (49 | ) | $ | 71 | |||||||||||||||||||
27-Dec-14 | |||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Balance Sheet | |||||||||||||||||||||||||||||||||
(In Millions) | Gross Amounts Recognized | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in the Balance Sheet | Financial Instruments | Cash and Non-Cash Collateral Received or Pledged | Net Amount | |||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Derivative assets subject to master netting arrangements | $ | 559 | $ | — | $ | 559 | $ | (365 | ) | $ | (78 | ) | $ | 116 | |||||||||||||||||||
Reverse repurchase agreements | 718 | — | 718 | — | (718 | ) | — | ||||||||||||||||||||||||||
Total assets | $ | 1,277 | $ | — | $ | 1,277 | $ | (365 | ) | $ | (796 | ) | $ | 116 | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities subject to master netting arrangements | $ | 559 | $ | — | $ | 559 | $ | (365 | ) | $ | (80 | ) | $ | 114 | |||||||||||||||||||
Total liabilities | $ | 559 | $ | — | $ | 559 | $ | (365 | ) | $ | (80 | ) | $ | 114 | |||||||||||||||||||
Derivatives in Cash Flow Hedging Relationships | |||||||||||||||||||||||||||||||||
The before-tax gains (losses), attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss) for each period were as follows: | |||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||||||||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||||||||||||||
Currency forwards | $ | (229 | ) | $ | 35 | ||||||||||||||||||||||||||||
Other | — | (2 | ) | ||||||||||||||||||||||||||||||
Total | $ | (229 | ) | $ | 33 | ||||||||||||||||||||||||||||
Gains and losses on derivative instruments in cash flow hedging relationships related to hedge ineffectiveness and amounts excluded from effectiveness testing, were insignificant during all periods presented in the preceding tables. Additionally, for all periods presented, there was an insignificant impact on results of operations from discontinued cash flow hedges, which arises when forecasted transactions are probable of not occurring. | |||||||||||||||||||||||||||||||||
For information on the unrealized holding gains (losses) on derivatives reclassified out of accumulated other comprehensive income into the consolidated condensed statements of income, see "Note 18: Other Comprehensive Income (Loss)." | |||||||||||||||||||||||||||||||||
Derivatives Not Designated as Hedging Instruments | |||||||||||||||||||||||||||||||||
The effects of derivative instruments not designated as hedging instruments on the consolidated condensed statements of income for each period were as follows: | |||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||
(In Millions) | Location of Gains (Losses) | Mar 28, | Mar 29, | ||||||||||||||||||||||||||||||
Recognized in Income on Derivatives | 2015 | 2014 | |||||||||||||||||||||||||||||||
Currency forwards | Interest and other, net | $ | (18 | ) | $ | (15 | ) | ||||||||||||||||||||||||||
Currency interest rate swaps | Interest and other, net | 253 | (54 | ) | |||||||||||||||||||||||||||||
Interest rate swaps | Interest and other, net | (6 | ) | — | |||||||||||||||||||||||||||||
Total return swaps | Various | 31 | 13 | ||||||||||||||||||||||||||||||
Other | Gains (losses) on equity investments, net | (9 | ) | 1 | |||||||||||||||||||||||||||||
Total | $ | 251 | $ | (55 | ) | ||||||||||||||||||||||||||||
Acquisitions
Acquisitions | 3 Months Ended |
Mar. 28, 2015 | |
Acquisitions [Abstract] | |
Acquisitions [Text Block] | Note 7: Acquisitions |
During the first three months of 2015, we completed one acquisition qualifying as a business combination in exchange for acquisition date consideration of $68 million, a majority of which was cash consideration. Substantially all of the consideration was allocated to goodwill. This acquisition was not significant to our results of operations. For information on goodwill by operating segment, see “Note 8: Goodwill”. |
Goodwill
Goodwill | 3 Months Ended | ||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||
Goodwill [Abstract] | |||||||||||||||||||||
Goodwill [Text Block] | Note 8: Goodwill | ||||||||||||||||||||
Goodwill activity for the first three months of 2015 was as follows: | |||||||||||||||||||||
(In Millions) | Dec 27, | Acquisitions | Transfers | Currency Exchange and Other | Mar 28, | ||||||||||||||||
2014 | 2015 | ||||||||||||||||||||
Client Computing Group | $ | — | $ | — | $ | 3,708 | $ | — | $ | 3,708 | |||||||||||
PC Client Group | 3,058 | — | (3,058 | ) | — | — | |||||||||||||||
Data Center Group | 2,376 | — | — | — | 2,376 | ||||||||||||||||
Internet of Things Group | 428 | — | — | — | 428 | ||||||||||||||||
Mobile and Communications Group | 650 | — | (650 | ) | — | — | |||||||||||||||
Software and services operating segments | 4,236 | — | — | (163 | ) | 4,073 | |||||||||||||||
All other | 113 | 68 | — | — | 181 | ||||||||||||||||
Total | $ | 10,861 | $ | 68 | $ | — | $ | (163 | ) | $ | 10,766 | ||||||||||
During the first quarter of 2015, we combined the PC Client Group (PCCG) and the Mobile and Communications Group (MCG) to create the Client Computing Group (CCG). Due to this reorganization, PCCG and MCG goodwill was transferred to CCG, shown in the preceding table as "Transfers." For further information, see "Note 20: Operating Segments Information." |
Identified_Intangible_Assets
Identified Intangible Assets | 3 Months Ended | ||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |||||||||||||||||||||
Identified Intangible Assets [Text Block] | Note 9: Identified Intangible Assets | ||||||||||||||||||||
Identified intangible assets at the end of each period were as follows: | |||||||||||||||||||||
28-Mar-15 | |||||||||||||||||||||
(In Millions) | Gross Assets | Accumulated | Net | ||||||||||||||||||
Amortization | |||||||||||||||||||||
Acquisition-related developed technology | $ | 2,964 | $ | (2,273 | ) | $ | 691 | ||||||||||||||
Acquisition-related customer relationships | 1,644 | (1,024 | ) | 620 | |||||||||||||||||
Acquisition-related trade names | 61 | (51 | ) | 10 | |||||||||||||||||
Licensed technology and patents | 3,082 | (1,159 | ) | 1,923 | |||||||||||||||||
Identified intangible assets subject to amortization | 7,751 | (4,507 | ) | 3,244 | |||||||||||||||||
Acquisition-related trade names | 764 | — | 764 | ||||||||||||||||||
Other intangible assets | 203 | — | 203 | ||||||||||||||||||
Identified intangible assets not subject to amortization | 967 | — | 967 | ||||||||||||||||||
Total identified intangible assets | $ | 8,718 | $ | (4,507 | ) | $ | 4,211 | ||||||||||||||
December 27, 2014 | |||||||||||||||||||||
(In Millions) | Gross Assets | Accumulated | Net | ||||||||||||||||||
Amortization | |||||||||||||||||||||
Acquisition-related developed technology | $ | 3,009 | $ | (2,192 | ) | $ | 817 | ||||||||||||||
Acquisition-related customer relationships | 1,698 | (1,001 | ) | 697 | |||||||||||||||||
Acquisition-related trade names | 61 | (49 | ) | 12 | |||||||||||||||||
Licensed technology and patents | 3,153 | (1,224 | ) | 1,929 | |||||||||||||||||
Identified intangible assets subject to amortization | 7,921 | (4,466 | ) | 3,455 | |||||||||||||||||
Acquisition-related trade names | 788 | — | 788 | ||||||||||||||||||
Other intangible assets | 203 | — | 203 | ||||||||||||||||||
Identified intangible assets not subject to amortization | 991 | — | 991 | ||||||||||||||||||
Total identified intangible assets | $ | 8,912 | $ | (4,466 | ) | $ | 4,446 | ||||||||||||||
Amortization expenses, with presentation location on the consolidated condensed statements of income, for each period were as follows: | |||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||
(In Millions) | Location | Mar 28, | Mar 29, | ||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||
Acquisition-related developed technology | Cost of sales | $ | 120 | $ | 146 | ||||||||||||||||
Acquisition-related customer relationships | Amortization of acquisition-related intangibles | 60 | 70 | ||||||||||||||||||
Acquisition-related trade names | Amortization of acquisition-related intangibles | 2 | 3 | ||||||||||||||||||
Licensed technology and patents | Cost of sales | 69 | 68 | ||||||||||||||||||
Total amortization expenses | $ | 251 | $ | 287 | |||||||||||||||||
Based on identified intangible assets that are subject to amortization as of March 28, 2015, we expect future amortization expenses for each period to be as follows: | |||||||||||||||||||||
(In Millions) | Remainder of 2015 | 2016 | 2017 | 2018 | 2019 | ||||||||||||||||
Acquisition-related developed technology | $ | 210 | $ | 239 | $ | 90 | $ | 69 | $ | 60 | |||||||||||
Acquisition-related customer relationships | 179 | 223 | 137 | 34 | 15 | ||||||||||||||||
Acquisition-related trade names | 7 | 3 | — | — | — | ||||||||||||||||
Licensed technology and patents | 207 | 262 | 219 | 177 | 176 | ||||||||||||||||
Total future amortization expenses | $ | 603 | $ | 727 | $ | 446 | $ | 280 | $ | 251 | |||||||||||
Other_LongTerm_Assets
Other Long-Term Assets | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Other Assets, Noncurrent Disclosure [Abstract] | |||||||||
Other Long-Term Assets [Text Block] | Note 10: Other Long-Term Assets | ||||||||
Other long-term assets at the end of each period were as follows: | |||||||||
(In Millions) | Mar 28, | Dec 27, | |||||||
2015 | 2014 | ||||||||
Equity method investments | $ | 1,574 | $ | 1,446 | |||||
Non-marketable cost method investments | 1,800 | 1,769 | |||||||
Non-current deferred tax assets | 638 | 622 | |||||||
Pre-payments for property, plant and equipment | 515 | 636 | |||||||
Loans receivable | 316 | 416 | |||||||
Other | 1,760 | 1,672 | |||||||
Total other long-term assets | $ | 6,603 | $ | 6,561 | |||||
During the first three months of 2015, we received and transferred $179 million of equipment from other long-term assets to property, plant and equipment. The equipment was prepaid in 2012 and 2013. We recognized the pre-payments within operating activities in the consolidated condensed statement of cash flows when we paid for the equipment, and the receipt of the equipment is reflected as a non-cash transaction in the current period. |
Restructuring_and_Asset_Impair
Restructuring and Asset Impairment Charges | 3 Months Ended | ||||||||||||
Mar. 28, 2015 | |||||||||||||
Restructuring Costs and Asset Impairment Charges [Abstract] | |||||||||||||
Restructuring and Asset Impairment Charges [Text Block] | Note 11: Restructuring and Asset Impairment Charges | ||||||||||||
Beginning in the third quarter of 2013, management approved several restructuring actions, including targeted workforce reductions and the exit of certain businesses and facilities. These actions include the wind down of our 200 millimeter wafer fabrication facility in Massachusetts, which ceased production in the first quarter of 2015, and the closure of our assembly and test facility in Costa Rica, which ceased production in the fourth quarter of 2014. These targeted reductions will enable us to better align our resources in areas providing the greatest benefit in the current business environment. We expect these actions to be substantially complete by the end of 2015. | |||||||||||||
Restructuring and asset impairment charges for each period were as follows: | |||||||||||||
Three Months Ended | |||||||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||||||
2015 | 2014 | ||||||||||||
Employee severance and benefit arrangements | $ | 99 | $ | 137 | |||||||||
Asset impairments and other restructuring charges | 6 | — | |||||||||||
Total restructuring and asset impairment charges | $ | 105 | $ | 137 | |||||||||
Restructuring and asset impairment activity for the first three months of 2015 was as follows: | |||||||||||||
(In Millions) | Employee Severance and Benefits | Asset Impairments and Other | Total | ||||||||||
Accrued restructuring balance as of December 27, 2014 | $ | 121 | $ | 11 | $ | 132 | |||||||
Additional accruals | 99 | 7 | 106 | ||||||||||
Adjustments | — | (1 | ) | (1 | ) | ||||||||
Cash payments | (82 | ) | (4 | ) | (86 | ) | |||||||
Non-cash settlements | — | (2 | ) | (2 | ) | ||||||||
Accrued restructuring balance as of March 28, 2015 | $ | 138 | $ | 11 | $ | 149 | |||||||
We recorded the additional accruals and adjustments as restructuring and asset impairment charges in the consolidated condensed statements of income and within the “all other” operating segments category. Most of the accrued restructuring balance as of March 28, 2015 is expected to be paid within the next 12 months and was recorded as a current liability within accrued compensation and benefits on the consolidated condensed balance sheets. | |||||||||||||
Restructuring actions that were approved in 2015 impacted approximately 1,400 employees. Since the third quarter of 2013, we have incurred a total of $640 million in restructuring and asset impairment charges. These charges included a total of $565 million related to employee severance and benefit arrangements for approximately 9,000 employees, and $75 million in asset impairment charges and other restructuring charges. |
Deferred_Income
Deferred Income | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Deferred Income [Abstract] | |||||||||
Deferred Income [Text Block] | Note 12: Deferred Income | ||||||||
Deferred income at the end of each period was as follows: | |||||||||
(In Millions) | Mar 28, | Dec 27, | |||||||
2015 | 2014 | ||||||||
Deferred income on shipments of components to distributors | $ | 965 | $ | 944 | |||||
Deferred income from software and services | 1,231 | 1,261 | |||||||
Current deferred income | 2,196 | 2,205 | |||||||
Non-current deferred income from software and services | 428 | 483 | |||||||
Total deferred income | $ | 2,624 | $ | 2,688 | |||||
We classify non-current deferred income from software and services within other long-term liabilities on the consolidated condensed balance sheets. |
Employee_Equity_Incentive_Plan
Employee Equity Incentive Plans | 3 Months Ended | |||||||
Mar. 28, 2015 | ||||||||
Employee Benefits and Share-based Compensation [Abstract] | ||||||||
Employee Equity Incentive Plans [Text Block] | Note 13: Employee Equity Incentive Plans | |||||||
Our equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests. | ||||||||
As of March 28, 2015, 254 million shares of common stock remained available for future grant under the 2006 Equity Incentive Plan through June 2016. | ||||||||
The 2006 Stock Purchase Plan allows eligible employees to purchase shares of our common stock at 85% of the value of our common stock on specific dates. Rights to purchase shares of common stock are granted during the first and third quarters of each year. As of March 28, 2015, 189 million shares of common stock remained available for issuance under the 2006 Stock Purchase Plan through August 2016. | ||||||||
Share-Based Compensation | ||||||||
Share-based compensation recognized in the first three months of 2015 was $368 million ($283 million in the first three months of 2014). | ||||||||
Restricted Stock Unit Awards | ||||||||
Restricted stock unit activity in the first three months of 2015 was as follows: | ||||||||
Number of | Weighted Average | |||||||
RSUs | Grant-Date | |||||||
(In Millions) | Fair Value | |||||||
December 27, 2014 | 119.4 | $ | 23.89 | |||||
Granted | 6.7 | $ | 39.05 | |||||
Vested | (3.1 | ) | $ | 27.52 | ||||
Forfeited | (1.9 | ) | $ | 23.97 | ||||
March 28, 2015 | 121.1 | $ | 24.63 | |||||
As of March 28, 2015, 4.8 million of the outstanding restricted stock units were market-based restricted stock units. | ||||||||
Stock Option Awards | ||||||||
Stock option activity in the first three months of 2015 was as follows: | ||||||||
Number of | Weighted Average | |||||||
Options | Exercise Price | |||||||
(In Millions) | ||||||||
December 27, 2014 | 77.3 | $ | 21.3 | |||||
Exercised | (5.2 | ) | $ | 20.43 | ||||
Cancelled and forfeited | (0.4 | ) | $ | 23.07 | ||||
Expired | (0.1 | ) | $ | 21.97 | ||||
March 28, 2015 | 71.6 | $ | 21.35 | |||||
Options exercisable as of: | ||||||||
December 27, 2014 | 54.7 | $ | 20.29 | |||||
March 28, 2015 | 53.1 | $ | 20.41 | |||||
Stock Purchase Plan | ||||||||
Employees purchased 8.1 million shares of common stock in the first three months of 2015 for $234 million (10.7 million shares of common stock in the first three months of 2014 for $212 million) under the 2006 Stock Purchase Plan. |
Common_Stock_Repurchases
Common Stock Repurchases | 3 Months Ended |
Mar. 28, 2015 | |
Common Stock Repurchases [Abstract] | |
Common Stock Repurchases [Text Block] | Note 14: Common Stock Repurchases |
Common Stock Repurchase Program | |
We have an ongoing authorization, originally approved by our Board of Directors in 2005, and subsequently amended, to repurchase up to $65 billion in shares of our common stock in open market or negotiated transactions. As of March 28, 2015, $11.6 billion remained available for repurchase under the existing repurchase authorization limit. | |
During the first three months of 2015, we repurchased 21.3 million shares of common stock at a cost of $750 million (22.1 million shares of common stock at a cost of $545 million in the first three months of 2014). We have repurchased 4.7 billion shares of common stock at a cost of $103 billion since the program began in 1990. | |
During the fourth quarter of 2014, we entered into a stock repurchase agreement, a portion of which was executed as a forward contract. We received collateral from the counterparty for the value attributable to the forward portion of this contract and invested the collateral into permitted investments considered restricted from other uses. As of December 27, 2014, $325 million of collateral, which approximates fair value, was recorded as both a current asset and current liability on the consolidated condensed balance sheet. The full amount of the collateral was returned to the counterparty during the first quarter of 2015 when the contract settled. |
Gains_Losses_on_Equity_Investm
Gains (Losses) on Equity Investments, Net | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Gains (Losses) on Equity Investments, Net [Abstract] | |||||||||
Gains (Losses) on Equity Investments, Net [Text Block] | Note 15: Gains (Losses) on Equity Investments, Net | ||||||||
The components of gains (losses) on equity investments, net for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||
2015 | 2014 | ||||||||
Share of equity method investee losses, net | $ | (48 | ) | $ | (11 | ) | |||
Impairments | (38 | ) | (38 | ) | |||||
Gains on sales, net | 46 | 71 | |||||||
Other, net | 72 | 26 | |||||||
Total gains (losses) on equity investments, net | $ | 32 | $ | 48 | |||||
Interest_and_Other_Net
Interest and Other, Net | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Interest and Other, Net [Abstract] | |||||||||
Interest and Other, Net [Text Block] | Note 16: Interest and Other, Net | ||||||||
The components of interest and other, net for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||
2015 | 2014 | ||||||||
Interest income | $ | 32 | $ | 35 | |||||
Interest expense | (42 | ) | (37 | ) | |||||
Other, net | 36 | 114 | |||||||
Total interest and other, net | $ | 26 | $ | 112 | |||||
Interest expense in the preceding table is net of $81 million of interest capitalized in the first three months of 2015 ($77 million in the first three months of 2014). | |||||||||
During the first quarter of 2014, we completed the divestiture of our Intel Media assets. As a result of the transaction, we recognized a gain within "other, net" in the preceding table. |
Earnings_Per_Share
Earnings Per Share | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Earnings Per Share [Abstract] | |||||||||
Earnings Per Share [Text Block] | Note 17: Earnings Per Share | ||||||||
We computed our basic and diluted earnings per common share for each period as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions, Except Per Share Amounts) | Mar 28, | Mar 29, | |||||||
2015 | 2014 | ||||||||
Net income available to common stockholders | $ | 1,992 | $ | 1,930 | |||||
Weighted average shares of common stock outstanding—basic | 4,741 | 4,974 | |||||||
Dilutive effect of employee equity incentive plans | 82 | 76 | |||||||
Dilutive effect of convertible debt | 91 | 67 | |||||||
Weighted average shares of common stock outstanding—diluted | 4,914 | 5,117 | |||||||
Basic earnings per share of common stock | $ | 0.42 | $ | 0.39 | |||||
Diluted earnings per share of common stock | $ | 0.41 | $ | 0.38 | |||||
We computed basic earnings per share of common stock using net income available to common stockholders and the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings per share of common stock using net income available to common stockholders and the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period. Net income available to participating securities was insignificant for all periods presented. | |||||||||
Potentially dilutive shares of common stock from employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding restricted stock units, and the assumed issuance of common stock under the stock purchase plan. Potentially dilutive shares of common stock for our 2005 debentures are determined by applying the if-converted method. However, as our 2009 debentures require settlement of the principal amount of the debt in cash upon conversion, with the conversion premium paid in cash or stock at our option, potentially dilutive shares of common stock are determined by applying the treasury stock method. | |||||||||
During the first three months of 2015, we excluded on average 3 million outstanding stock options and restricted stock units from the computation of diluted earnings per share of common stock because these shares of common stock would have been antidilutive (33 million for the first three months of 2014). These options could potentially be included in the diluted earnings per share of common stock calculation in the future if the average market value of the shares of common stock increases and is greater than the exercise price of these options. | |||||||||
In the first three months of 2015 and 2014, we included our 2009 debentures in the calculation of diluted earnings per share of common stock because the average market price was above the conversion price. We could potentially exclude the 2009 debentures in the future if the average market price is below the conversion price. |
Other_Comprehensive_Income_Los
Other Comprehensive Income (Loss) | 3 Months Ended | ||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||
Other Comprehensive Income (Loss) [Text Block] | Note 18: Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||||
The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first three months of 2015 were as follows: | |||||||||||||||||||||||||||||
(In Millions) | Unrealized Holding Gains (Losses) on Available-for-Sale Investments | Deferred Tax Asset Valuation Allowance | Unrealized Holding Gains (Losses) on Derivatives | Prior Service Credits (Costs) | Actuarial Gains (Losses) | Foreign Currency Translation Adjustment | Total | ||||||||||||||||||||||
27-Dec-14 | $ | 2,459 | $ | 26 | $ | (423 | ) | $ | (47 | ) | $ | (1,004 | ) | $ | (345 | ) | $ | 666 | |||||||||||
Other comprehensive income (loss) before reclassifications | (472 | ) | — | (229 | ) | — | 2 | (197 | ) | (896 | ) | ||||||||||||||||||
Amounts reclassified out of accumulated other comprehensive income (loss) | (54 | ) | — | 99 | 2 | 14 | — | 61 | |||||||||||||||||||||
Tax effects | 184 | (3 | ) | 41 | — | (4 | ) | 19 | 237 | ||||||||||||||||||||
Other comprehensive income (loss) | (342 | ) | (3 | ) | (89 | ) | 2 | 12 | (178 | ) | (598 | ) | |||||||||||||||||
28-Mar-15 | $ | 2,117 | $ | 23 | $ | (512 | ) | $ | (45 | ) | $ | (992 | ) | $ | (523 | ) | $ | 68 | |||||||||||
The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated condensed statements of income, with presentation location, for each period were as follows: | |||||||||||||||||||||||||||||
Income Before Taxes Impact | |||||||||||||||||||||||||||||
(In Millions) | |||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||
Comprehensive Income Components | Mar 28, | Mar 29, | Location | ||||||||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||||||||||
Unrealized holding gains (losses) on available-for-sale investments: | |||||||||||||||||||||||||||||
$ | — | $ | 2 | Interest and other, net | |||||||||||||||||||||||||
54 | 61 | Gains (losses) on equity investments, net | |||||||||||||||||||||||||||
54 | 63 | ||||||||||||||||||||||||||||
Unrealized holding gains (losses) on derivatives: | |||||||||||||||||||||||||||||
Currency forwards | (43 | ) | 2 | Cost of sales | |||||||||||||||||||||||||
(47 | ) | 8 | Research and development | ||||||||||||||||||||||||||
(9 | ) | 2 | Marketing, general and administrative | ||||||||||||||||||||||||||
(99 | ) | 12 | |||||||||||||||||||||||||||
Amortization of pension and postretirement benefit components: | |||||||||||||||||||||||||||||
Prior service credits (costs) | (2 | ) | (1 | ) | |||||||||||||||||||||||||
Actuarial gains (losses) | (14 | ) | (10 | ) | |||||||||||||||||||||||||
(16 | ) | (11 | ) | ||||||||||||||||||||||||||
Total amounts reclassified out of accumulated other comprehensive income (loss) | $ | (61 | ) | $ | 64 | ||||||||||||||||||||||||
The amortization of pension and postretirement benefit components are included in the computation of net periodic benefit cost. For further information, see the "Retirement Benefit Plans" note in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 27, 2014. | |||||||||||||||||||||||||||||
We estimate that we will reclassify approximately $409 million (before taxes) of net derivative losses included in accumulated other comprehensive income (loss) into earnings within the next 12 months. |
Contingencies
Contingencies | 3 Months Ended |
Mar. 28, 2015 | |
Contingencies [Abstract] | |
Contingencies [Text Block] | Note 19: Contingencies |
Legal Proceedings | |
We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time. | |
Government Competition Matters and Related Consumer Class Actions | |
A number of proceedings generally have challenged and continue to challenge certain of our competitive practices. The allegations in these proceedings vary and are described in more detail in the following paragraphs. In general, they contend that we improperly conditioned price rebates and other discounts on our microprocessors on exclusive or near-exclusive dealing by some of our customers; and they allege that our software compiler business unfairly preferred Intel® microprocessors over competing microprocessors and that, through the use of our compilers and other means, we have caused the dissemination of inaccurate and misleading benchmark results concerning our microprocessors. Based on the procedural posture of the various remaining competition matters, which we describe in the following paragraphs, our investment of resources to explain and defend our position has declined as compared to the period 2005-2011. Nonetheless, certain of the matters remain active, and these challenges could continue for a number of years, potentially requiring us to invest additional resources. We believe that we compete lawfully and that our marketing, business, intellectual property, and other challenged practices benefit our customers and our stockholders, and we will continue to conduct a vigorous defense in the remaining proceedings. | |
In 2001, the European Commission (EC) commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.06 billion ($1.447 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision. | |
The EC decision contained no specific direction on whether or how we should modify our business practices. Instead, the decision stated that we should "cease and desist" from further conduct that, in the EC's opinion, would violate applicable law. We took steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices. | |
We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place in July 2012. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. On November 11, 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The EC and interveners filed briefs in November 2014, we filed a reply in February 2015, and the EC filed a rejoinder in April 2015. The Court of Justice is likely to hold oral argument in late 2015 and issue its decision in 2016. | |
At least 82 separate class-action lawsuits have been filed in the U.S. District Courts for the Northern District of California, Southern District of California, District of Idaho, District of Nebraska, District of New Mexico, District of Maine, and District of Delaware, as well as in various California, Kansas, and Tennessee state courts. These actions generally repeat the allegations made in a now-settled lawsuit filed against us by AMD in June 2005 in the U.S. District Court for the District of Delaware (AMD litigation). Like the AMD litigation, these class-action lawsuits allege that we engaged in various actions in violation of the Sherman Act and other laws by, among other things: providing discounts and rebates to our manufacturer and distributor customers conditioned on exclusive or near-exclusive dealing that allegedly unfairly interfered with AMD's ability to sell its microprocessors; interfering with certain AMD product launches; and interfering with AMD's participation in certain industry standards-setting groups. The class actions allege various consumer injuries, including that consumers in various states have been injured by paying higher prices for computers containing our microprocessors. We dispute these class-action claims and intend to defend the lawsuits vigorously. | |
All of the federal and state class actions other than the California class actions were transferred by the Multidistrict Litigation Panel to the U.S. District Court in Delaware for all pre-trial proceedings and discovery (MDL proceedings). The Delaware district court appointed a Special Master to address issues in the MDL proceedings, as assigned by the court. In January 2010, the plaintiffs in the Delaware action filed a motion for sanctions for our alleged failure to preserve evidence. This motion largely copies a motion previously filed by AMD in the AMD litigation, which has settled. The plaintiffs in the MDL proceedings also moved for certification of a class of members who purchased certain personal computers containing products sold by us. In July 2010, the Special Master issued a Report and Recommendation (Report) denying the motion to certify a class. The MDL plaintiffs filed objections to the Special Master's Report, and a hearing on those objections was held before the district court in July 2013. In July 2014, the district court affirmed the Special Master's ruling and issued an order denying the MDL plaintiffs' motion for class certification. In August 2014, plaintiffs filed a petition for interlocutory appeal of the district court's decision with the U.S. Court of Appeals for the Third Circuit, which the Third Circuit denied in October 2014. In December 2014, Intel filed a motion for summary judgment on the claims of the remaining individual plaintiffs. | |
All California class actions have been consolidated in the Superior Court of California in Santa Clara County. The plaintiffs in the California actions moved for class certification, which we are in the process of opposing. At our request, the court in the California actions agreed to delay ruling on this motion until after the Delaware district court ruled on the similar motion in the MDL proceedings. The plaintiffs asked the court for leave to retain a new expert and to amend their previous motion for class certification. The court granted plaintiffs’ request in February 2015 and the hearing on plaintiffs’ amended class certification motion is set for November 6, 2015. Given the procedural posture and the nature of these cases, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. | |
In re High Tech Employee Antitrust Litigation | |
Between May and July 2011, former employees of Intel, Adobe Systems Incorporated, Apple Inc., Google Inc., Intuit Inc., Lucasfilm Ltd., and Pixar filed antitrust class action lawsuits in the California Superior Courts alleging that these companies had entered into a conspiracy to suppress the compensation of their employees. The lawsuits were removed to the United States District Court for the Northern District of California, and in September 2011 the plaintiffs filed a consolidated amended complaint, captioned In re High Tech Employee Antitrust Litigation. The plaintiffs’ allegations reference the 2009 and 2010 investigation by the Department of Justice (DOJ) into employment practices in the technology industry, as well as the DOJ’s complaints and subsequent stipulated final judgments with the seven companies named as defendants in the lawsuits. The plaintiffs allege that the defendants entered into certain unlawful agreements not to cold call employees of particular other defendants and that there was an overarching conspiracy among the defendants. Plaintiffs assert one such agreement specific to Intel, namely that Intel and Google entered into an agreement starting in 2005, not to cold call each other's employees. Plaintiffs assert claims under Section 1 of the Sherman Antitrust Act and Section 4 of the Clayton Antitrust Act and seek a declaration that the defendants’ alleged actions violated the antitrust laws, damages trebled as provided for by law under the Sherman Act or Clayton Act, restitution and disgorgement, and attorneys’ fees and costs. | |
In October 2013, the district court certified a class consisting of approximately 65,000 current or former employees of the seven defendants and set the matter for trial in late May 2014. The so-called "technical class" consists of a group of current and former technical, creative, and R&D employees at each of the defendants. In January 2014, Intel filed a motion for summary judgment, which the court denied in March 2014. | |
In April 2014, Intel, Adobe, Apple, and Google reached an agreement with plaintiffs to settle this lawsuit, but in August 2014, the district court denied preliminary approval of the settlement. In September 2014, defendants filed a petition for writ of mandamus asking the U.S. Court of Appeals for the Ninth Circuit to reverse the district court’s decision. The Ninth Circuit ordered briefing and scheduled a March 2015 hearing date on the writ petition. Defendants have withdrawn the petition for writ of mandamus in light of the settlement agreement discussed below. | |
In January 2015, Intel, Adobe, Apple, and Google reached a second agreement with plaintiffs to settle this lawsuit, which the court preliminarily approved in March 2015; the final fairness hearing is scheduled for July 2015. We continue to dispute the plaintiffs’ claims, but have agreed to settle this lawsuit to avoid the uncertainties, expenses, and diversion of resources from continued litigation. Our operating expenses for 2014 reflect accruals for this proceeding and we believe reasonably possible losses in excess of the accrued amount are not material to our financial statements. | |
In re Intel Corporation Shareholder Derivative Litigation | |
In March 2014, the Police Retirement System of St. Louis filed a shareholder derivative action in the Superior Court of California in Santa Clara County against the members of our Board of Directors, certain former Board members, and a current officer. The complaint alleges that the defendants breached their duties to the company by participating in, or allowing, alleged antitrust violations, as described in In re High Tech Employee Antitrust Litigation. In March 2014, a second plaintiff, Barbara Templeton, filed a substantially similar derivative suit in the same court. In May 2014, a third shareholder, Robert Achermann, filed a substantially similar derivative action in the same court. The court consolidated the three actions into one, which is captioned In re Intel Corporation Shareholder Derivative Litigation. Plaintiffs filed a consolidated complaint in July 2014. In September 2014, the court granted our motion to dismiss the consolidated complaint, but granted plaintiffs leave to amend. Plaintiffs filed an amended complaint in February 2015. Intel moved to dismiss the amended complaint in March 2015, and a hearing on the motion is scheduled for June 2015. | |
Lehman Brothers Holdings Inc. and Lehman Brothers OTC Derivatives Inc. v. Intel | |
In May 2013, Lehman Brothers OTC Derivatives Inc. (LOTC) and Lehman Brothers Holdings Inc. (LBHI) filed an adversary complaint in the United States Bankruptcy Court in the Southern District of New York asserting claims against us arising from a 2008 contract between Intel and LOTC. Under the terms of the 2008 contract, we prepaid $1.0 billion to LOTC, in exchange for which LOTC was required to deliver to us on or before September 29, 2008, quantities of Intel common stock and cash determined by a formula set forth in the contract. LOTC's performance under the contract was secured by $1.0 billion of cash collateral. Under the terms of the contract, LOTC was obligated to deliver approximately 50 million shares of our common stock to us on September 29, 2008. LOTC failed to deliver any Intel common stock or cash, and we exercised our right of setoff against the $1.0 billion collateral. LOTC and LBHI acknowledge in their complaint that we were entitled to set off our losses against the collateral, but they assert that we withheld collateral in excess of our losses that should have been returned to LOTC. The complaint asserts a claim for breach of contract, a claim for turnover under section 542(a) of the Bankruptcy Code, and a claim for violation of the automatic stay under section 362(a)(3) of the Bankruptcy Code. The complaint does not expressly quantify the amount of damages claimed but does assert multiple theories of damages that impliedly seek up to $312 million of alleged excess collateral, plus interest at LIBOR plus 13.5%, compounded daily. In June 2013, we filed a motion to dismiss plaintiffs' bankruptcy claims and for a determination that the breach of contract claim is "non-core" under the Bankruptcy Code. The bankruptcy court granted our motion in its entirety in December 2013. In May 2014, the United States District Court for the Southern District of New York denied our request that it withdraw its reference of plaintiffs' adversary complaint to the bankruptcy court. In January 2015, Intel and the plaintiffs filed competing motions for summary judgment, which are scheduled for hearing in June 2015. Plaintiffs' motion requests judgment against Intel "in the amount of no less than" $129 million, plus interest. We believe that $129 million, plus interest, represents the upper end of the range of reasonably possible loss for this case, although we believe that we acted in a manner consistent with our contractual rights and intend to defend against any claim to the contrary. | |
McAfee, Inc. Shareholder Litigation | |
On August 19, 2010, we announced that we had agreed to acquire all of the common stock of McAfee, Inc. (McAfee) for $48.00 per share. Four McAfee shareholders filed putative class-action lawsuits in Santa Clara County, California Superior Court challenging the proposed transaction. The cases were ordered consolidated in September 2010. Plaintiffs filed an amended complaint that named former McAfee board members, McAfee and Intel as defendants, and alleged that the McAfee board members breached their fiduciary duties and that McAfee and Intel aided and abetted those breaches of duty. The complaint requested rescission of the merger agreement, such other equitable relief as the court may deem proper, and an award of damages in an unspecified amount. In June 2012, the plaintiffs’ damages expert asserted that the value of a McAfee share for the purposes of assessing damages should be $62.08. | |
In January 2012, the court certified the action as a class action, appointed the Central Pension Laborers’ Fund to act as the class representative, and scheduled trial to begin in January 2013. In March 2012, defendants filed a petition with the California Court of Appeal for a writ of mandate to reverse the class certification order; the petition was denied in June 2012. In March 2012, at defendants’ request, the court held that plaintiffs were not entitled to a jury trial, and ordered a bench trial. In April 2012, plaintiffs filed a petition with the California Court of Appeal for a writ of mandate to reverse that order, which the court of appeal denied in July 2012. In August 2012, defendants filed a motion for summary judgment. The trial court granted that motion in November 2012, and entered final judgment in the case in February 2013. In April 2013, plaintiffs appealed the final judgment. Intel, McAfee, and McAfee’s board of directors filed an opposition to plaintiff’s appeal in December 2014. Because the resolution of the appeal may materially impact the scope and nature of the proceeding, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from this matter. We dispute the class-action claims and intend to continue to defend the lawsuit vigorously. |
Operating_Segments_Information
Operating Segments Information | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Segment Reporting [Abstract] | |||||||||
Operating Segments Information [Text Block] | Note 20: Operating Segments Information | ||||||||
Our operating segments in effect as of March 28, 2015 include: | |||||||||
• Client Computing Group | • All other | ||||||||
• Data Center Group | • Non-Volatile Memory Solutions Group | ||||||||
• Internet of Things Group | • New Devices Group | ||||||||
• Software and services operating segments | |||||||||
• McAfee | |||||||||
• Software and Services Group | |||||||||
During the first quarter of 2015, we combined the PC Client Group and Mobile and Communications Group to create the Client Computing Group (CCG). This change in our organizational structure reflects our strategy to address all aspects of the client computing market segment and utilize our intellectual property to offer compelling customer solutions. All prior-period amounts have been retrospectively adjusted to reflect the way we internally manage and monitor segment performance starting in fiscal year 2015 and includes other minor reorganizations. | |||||||||
The Chief Operating Decision Maker (CODM) is our CEO. The CODM allocates resources to and assesses the performance of each operating segment using information about its revenue and operating income (loss). | |||||||||
We manage our business activities primarily based on a product segmentation basis. CCG and Data Center Group are our reportable operating segments. Internet of Things Group and the aggregated “software and services operating segments” as shown in the preceding operating segment list, do not meet the quantitative thresholds to qualify as reportable operating segments; however, we have elected to disclose the results of these non-reportable operating segments. Our Non-Volatile Memory Solutions Group and New Devices Group operating segments do not meet the quantitative thresholds to qualify as reportable segments and their combined results are included within the “all other” category. | |||||||||
Revenue for our reportable and aggregated non-reportable operating segments is primarily related to the following product lines: | |||||||||
• | Client Computing Group. Includes platforms designed for the notebook (including Ultrabook™ devices), 2 in 1 systems, the desktop (including all-in-ones and high-end enthusiast PCs), tablets, and smartphones; wireless and wired connectivity products; as well as mobile communication components. | ||||||||
• | Data Center Group. Includes server, network, and storage platforms designed for enterprise, cloud, communications infrastructure, and technical computing segments. | ||||||||
• | Internet of Things Group. Includes platforms designed for embedded market segments including retail, transportation, industrial, and buildings and home, along with a broad range of other market segments. | ||||||||
• | Software and services operating segments. Includes software and hardware products for endpoint security, network and content security, risk and compliance, and consumer and mobile security from our McAfee business, and software products and services that promote Intel architecture as the platform of choice for software development. | ||||||||
We have sales and marketing, manufacturing, engineering, finance, and administration groups. Expenses for these groups are generally allocated to the operating segments, and the expenses are included in the following operating results. | |||||||||
The “all other” category includes revenue, expenses, and charges such as: | |||||||||
• | results of operations from our Non-Volatile Memory Solutions Group and New Devices Group; | ||||||||
• | amounts included within restructuring and asset impairment charges; | ||||||||
• | a portion of profit-dependent compensation and other expenses not allocated to the operating segments; | ||||||||
• | divested businesses for which discrete operating results are not regularly reviewed by our CODM; | ||||||||
• | results of operations of start-up businesses that support our initiatives, including our foundry business; and | ||||||||
• | acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill. | ||||||||
The CODM does not evaluate operating segments using discrete asset information. Operating segments do not record inter-segment revenue. We do not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Although the CODM uses operating income to evaluate the segments, operating costs included in one segment may benefit other segments. Except for these differences, the accounting policies for segment reporting are the same as for Intel as a whole. | |||||||||
Net revenue and operating income (loss) for each period were as follows: | |||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||
2015 | 2014 | ||||||||
Net revenue: | |||||||||
Client Computing Group | $ | 7,420 | $ | 8,097 | |||||
Data Center Group | 3,679 | 3,087 | |||||||
Internet of Things Group | 533 | 482 | |||||||
Software and services operating segments | 534 | 553 | |||||||
All other | 615 | 545 | |||||||
Total net revenue | 12,781 | 12,764 | |||||||
Operating income (loss): | |||||||||
Client Computing Group | 1,410 | 1,847 | |||||||
Data Center Group | 1,701 | 1,336 | |||||||
Internet of Things Group | 87 | 115 | |||||||
Software and services operating segments | 3 | 8 | |||||||
All other | (586 | ) | (796 | ) | |||||
Total operating income | $ | 2,615 | $ | 2,510 | |||||
Fair_Value_Tables
Fair Value (Tables) | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | Assets and liabilities measured and recorded at fair value on a recurring basis at the end of each period were as follows: | ||||||||||||||||||||||||||||||||
28-Mar-15 | 27-Dec-14 | ||||||||||||||||||||||||||||||||
Fair Value Measured and Recorded at Reporting Date Using | Fair Value Measured and Recorded at Reporting Date Using | ||||||||||||||||||||||||||||||||
(In Millions) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||
Corporate debt | $ | — | $ | 742 | $ | — | $ | 742 | $ | — | $ | 48 | $ | — | $ | 48 | |||||||||||||||||
Financial institution instruments | 226 | 2,172 | — | 2,398 | 321 | 1,119 | — | 1,440 | |||||||||||||||||||||||||
Government debt | — | 50 | — | 50 | — | — | — | — | |||||||||||||||||||||||||
Reverse repurchase agreements | — | 238 | — | 238 | — | 268 | — | 268 | |||||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||||||||||
Corporate debt | 262 | 509 | 32 | 803 | 363 | 412 | 31 | 806 | |||||||||||||||||||||||||
Financial institution instruments | 100 | 502 | — | 602 | 149 | 1,050 | — | 1,199 | |||||||||||||||||||||||||
Government debt | 108 | 351 | — | 459 | 252 | 173 | — | 425 | |||||||||||||||||||||||||
Trading assets: | |||||||||||||||||||||||||||||||||
Asset-backed securities | — | 668 | 40 | 708 | — | 766 | 58 | 824 | |||||||||||||||||||||||||
Corporate debt | 1,922 | 576 | — | 2,498 | 2,625 | 339 | — | 2,964 | |||||||||||||||||||||||||
Financial institution instruments | 950 | 615 | — | 1,565 | 1,146 | 613 | — | 1,759 | |||||||||||||||||||||||||
Government debt | 1,077 | 2,162 | — | 3,239 | 1,295 | 2,221 | — | 3,516 | |||||||||||||||||||||||||
Other current assets: | |||||||||||||||||||||||||||||||||
Derivative assets | — | 776 | 2 | 778 | — | 559 | 2 | 561 | |||||||||||||||||||||||||
Loans receivable | — | 332 | — | 332 | — | 505 | — | 505 | |||||||||||||||||||||||||
Marketable equity securities | 6,487 | — | 62 | 6,549 | 7,097 | — | — | 7,097 | |||||||||||||||||||||||||
Other long-term investments: | |||||||||||||||||||||||||||||||||
Asset-backed securities | — | 2 | 4 | 6 | — | 2 | 4 | 6 | |||||||||||||||||||||||||
Corporate debt | 542 | 519 | 13 | 1,074 | 453 | 728 | 13 | 1,194 | |||||||||||||||||||||||||
Financial institution instruments | 197 | 255 | — | 452 | 189 | 319 | — | 508 | |||||||||||||||||||||||||
Government debt | 68 | 75 | — | 143 | 75 | 240 | — | 315 | |||||||||||||||||||||||||
Other long-term assets: | |||||||||||||||||||||||||||||||||
Derivative assets | — | 68 | 16 | 84 | — | 35 | 22 | 57 | |||||||||||||||||||||||||
Loans receivable | — | 316 | — | 316 | — | 216 | — | 216 | |||||||||||||||||||||||||
Total assets measured and recorded at fair value | 11,939 | 10,928 | 169 | 23,036 | 13,965 | 9,613 | 130 | 23,708 | |||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||||||
Other accrued liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities | — | 596 | 2 | 598 | — | 563 | — | 563 | |||||||||||||||||||||||||
Other long-term liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities | — | 13 | — | 13 | — | 17 | — | 17 | |||||||||||||||||||||||||
Total liabilities measured and recorded at fair value | $ | — | $ | 609 | $ | 2 | $ | 611 | $ | — | $ | 580 | $ | — | $ | 580 | |||||||||||||||||
Financial Instruments Not Recorded At Fair Value On Recurring Basis [Table Text Block] | The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows: | ||||||||||||||||||||||||||||||||
28-Mar-15 | |||||||||||||||||||||||||||||||||
(In Millions) | Carrying | Fair Value Measured Using | Fair Value | ||||||||||||||||||||||||||||||
Amount | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||
Grants receivable | $ | 660 | $ | — | $ | 662 | $ | — | $ | 662 | |||||||||||||||||||||||
Loans receivable | $ | 250 | $ | — | $ | 250 | $ | — | $ | 250 | |||||||||||||||||||||||
Non-marketable cost method investments | $ | 1,800 | $ | — | $ | — | $ | 2,690 | $ | 2,690 | |||||||||||||||||||||||
Reverse repurchase agreements | $ | 450 | $ | — | $ | 450 | $ | — | $ | 450 | |||||||||||||||||||||||
Short-term debt | $ | 1,092 | $ | — | $ | 1,734 | $ | — | $ | 1,734 | |||||||||||||||||||||||
Long-term debt | $ | 12,112 | $ | 10,825 | $ | 2,138 | $ | — | $ | 12,963 | |||||||||||||||||||||||
NVIDIA Corporation cross-license agreement liability | $ | 196 | $ | — | $ | 199 | $ | — | $ | 199 | |||||||||||||||||||||||
27-Dec-14 | |||||||||||||||||||||||||||||||||
(In Millions) | Carrying | Fair Value Measured Using | Fair Value | ||||||||||||||||||||||||||||||
Amount | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||
Grants receivable | $ | 676 | $ | — | $ | 679 | $ | — | $ | 679 | |||||||||||||||||||||||
Loans receivable | $ | 250 | $ | — | $ | 250 | $ | — | $ | 250 | |||||||||||||||||||||||
Non-marketable cost method investments | $ | 1,769 | $ | — | $ | — | $ | 2,599 | $ | 2,599 | |||||||||||||||||||||||
Reverse repurchase agreements | $ | 450 | $ | — | $ | 450 | $ | — | $ | 450 | |||||||||||||||||||||||
Short-term debt | $ | 1,588 | $ | — | $ | 2,145 | $ | — | $ | 2,145 | |||||||||||||||||||||||
Long-term debt | $ | 12,107 | $ | 11,467 | $ | 1,309 | $ | — | $ | 12,776 | |||||||||||||||||||||||
NVIDIA Corporation cross-license agreement liability | $ | 395 | $ | — | $ | 399 | $ | — | $ | 399 | |||||||||||||||||||||||
Cash_and_Investments_Tables
Cash and Investments (Tables) | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||||||
Investments and Cash [Abstract] | |||||||||||||||||||||||||||||||||
Schedule of Total Cash and Investments [Table Text Block] | Cash and investments at the end of each period were as follows: | ||||||||||||||||||||||||||||||||
(In Millions) | Mar 28, | Dec 27, | |||||||||||||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||||||||||||||
Available-for-sale investments | $ | 13,278 | $ | 13,038 | |||||||||||||||||||||||||||||
Cash | 816 | 805 | |||||||||||||||||||||||||||||||
Equity method investments | 1,574 | 1,446 | |||||||||||||||||||||||||||||||
Loans receivable | 898 | 971 | |||||||||||||||||||||||||||||||
Non-marketable cost method investments | 1,800 | 1,769 | |||||||||||||||||||||||||||||||
Reverse repurchase agreements | 688 | 718 | |||||||||||||||||||||||||||||||
Trading assets | 8,010 | 9,063 | |||||||||||||||||||||||||||||||
Total cash and investments | $ | 27,064 | $ | 27,810 | |||||||||||||||||||||||||||||
Schedule of Available-For-Sale Securities [Line Items] | |||||||||||||||||||||||||||||||||
Schedule of Available-for-sale Securities Reconciliation [Table Text Block] | Available-for-sale investments at the end of each period were as follows: | ||||||||||||||||||||||||||||||||
28-Mar-15 | 27-Dec-14 | ||||||||||||||||||||||||||||||||
(In Millions) | Adjusted Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Adjusted Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||||||||||||||
Asset-backed securities | $ | 8 | $ | — | $ | (2 | ) | $ | 6 | $ | 8 | $ | — | $ | (2 | ) | $ | 6 | |||||||||||||||
Corporate debt | 2,609 | 15 | (5 | ) | 2,619 | 2,040 | 13 | (5 | ) | 2,048 | |||||||||||||||||||||||
Financial institution instruments | 3,452 | 1 | (1 | ) | 3,452 | 3,146 | 2 | (1 | ) | 3,147 | |||||||||||||||||||||||
Government debt | 651 | 1 | — | 652 | 741 | — | (1 | ) | 740 | ||||||||||||||||||||||||
Marketable equity securities | 3,300 | 3,255 | (6 | ) | 6,549 | 3,318 | 3,779 | — | 7,097 | ||||||||||||||||||||||||
Total available-for-sale investments | $ | 10,020 | $ | 3,272 | $ | (14 | ) | $ | 13,278 | $ | 9,253 | $ | 3,794 | $ | (9 | ) | $ | 13,038 | |||||||||||||||
Available-for-sale Securities [Member] | |||||||||||||||||||||||||||||||||
Schedule of Available-For-Sale Securities [Line Items] | |||||||||||||||||||||||||||||||||
Investments Classified by Contractual Maturity Date [Table Text Block] | The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of March 28, 2015, were as follows: | ||||||||||||||||||||||||||||||||
(In Millions) | Cost | Fair Value | |||||||||||||||||||||||||||||||
Due in 1 year or less | $ | 4,697 | $ | 4,707 | |||||||||||||||||||||||||||||
Due in 1–2 years | 864 | 865 | |||||||||||||||||||||||||||||||
Due in 2–5 years | 779 | 778 | |||||||||||||||||||||||||||||||
Instruments not due at a single maturity date | 380 | 379 | |||||||||||||||||||||||||||||||
Total | $ | 6,720 | $ | 6,729 | |||||||||||||||||||||||||||||
Inventories_Tables
Inventories (Tables) | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Inventory, Net [Abstract] | |||||||||
Schedule of Inventory, Current [Table Text Block] | Inventories at the end of each period were as follows: | ||||||||
(In Millions) | Mar 28, | Dec 27, | |||||||
2015 | 2014 | ||||||||
Raw materials | $ | 528 | $ | 462 | |||||
Work in process | 2,190 | 2,375 | |||||||
Finished goods | 1,700 | 1,436 | |||||||
Total inventories | $ | 4,418 | $ | 4,273 | |||||
Derivative_Financial_Instrumen1
Derivative Financial Instruments (Tables) | 3 Months Ended | ||||||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||||||
Derivative [Line Items] | |||||||||||||||||||||||||||||||||
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] | Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: | ||||||||||||||||||||||||||||||||
(In Millions) | Mar 28, | Dec 27, | Mar 29, | ||||||||||||||||||||||||||||||
2015 | 2014 | 2014 | |||||||||||||||||||||||||||||||
Currency forwards | $ | 16,192 | $ | 15,578 | $ | 11,729 | |||||||||||||||||||||||||||
Currency interest rate swaps | 5,094 | 5,446 | 4,795 | ||||||||||||||||||||||||||||||
Embedded debt derivatives | 3,600 | 3,600 | 3,600 | ||||||||||||||||||||||||||||||
Interest rate swaps | 1,128 | 1,347 | 1,311 | ||||||||||||||||||||||||||||||
Total return swaps | 1,106 | 1,056 | 989 | ||||||||||||||||||||||||||||||
Other | 72 | 49 | 60 | ||||||||||||||||||||||||||||||
Total | $ | 27,192 | $ | 27,076 | $ | 22,484 | |||||||||||||||||||||||||||
The gross notional amounts for currency forwards and currency interest rate swaps (presented by currency) at the end of each period were as follows: | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 28, | Dec 27, | Mar 29, | ||||||||||||||||||||||||||||||
2015 | 2014 | 2014 | |||||||||||||||||||||||||||||||
British pound sterling | $ | 314 | $ | 410 | $ | 487 | |||||||||||||||||||||||||||
Chinese yuan | 4,079 | 3,097 | 1,291 | ||||||||||||||||||||||||||||||
Euro | 7,332 | 7,486 | 6,199 | ||||||||||||||||||||||||||||||
Indian rupee | 420 | 418 | 252 | ||||||||||||||||||||||||||||||
Israeli shekel | 2,010 | 2,489 | 1,878 | ||||||||||||||||||||||||||||||
Japanese yen | 4,206 | 3,779 | 3,542 | ||||||||||||||||||||||||||||||
Malaysian ringgit | 827 | 902 | 524 | ||||||||||||||||||||||||||||||
Swiss franc | 1,146 | 1,289 | 1,256 | ||||||||||||||||||||||||||||||
Other | 952 | 1,154 | 1,095 | ||||||||||||||||||||||||||||||
Total | $ | 21,286 | $ | 21,024 | $ | 16,524 | |||||||||||||||||||||||||||
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] | The fair value of our derivative instruments at the end of each period were as follows: | ||||||||||||||||||||||||||||||||
March 28, 2015 | December 27, 2014 | ||||||||||||||||||||||||||||||||
(In Millions) | Other | Other | Other | Other | Other | Other | Other | Other | |||||||||||||||||||||||||
Current | Long-Term | Accrued | Long-Term | Current | Long-Term | Accrued | Long-Term | ||||||||||||||||||||||||||
Assets | Assets | Liabilities | Liabilities | Assets | Assets | Liabilities | Liabilities | ||||||||||||||||||||||||||
Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||||||
Currency forwards | $ | 12 | $ | 3 | $ | 483 | $ | 5 | $ | 6 | $ | 1 | $ | 497 | $ | 9 | |||||||||||||||||
Total derivatives designated as hedging instruments | 12 | 3 | 483 | 5 | 6 | 1 | 497 | 9 | |||||||||||||||||||||||||
Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||
Currency forwards | 253 | — | 87 | — | 207 | — | 44 | — | |||||||||||||||||||||||||
Currency interest rate swaps | 510 | 65 | 12 | — | 344 | 34 | 7 | — | |||||||||||||||||||||||||
Embedded debt derivatives | — | — | 1 | 8 | — | — | 4 | 8 | |||||||||||||||||||||||||
Interest rate swaps | 1 | — | 13 | — | 3 | — | 11 | — | |||||||||||||||||||||||||
Other | 2 | 16 | 2 | — | 1 | 22 | — | — | |||||||||||||||||||||||||
Total derivatives not designated as hedging instruments | 766 | 81 | 115 | 8 | 555 | 56 | 66 | 8 | |||||||||||||||||||||||||
Total derivatives | $ | 778 | $ | 84 | $ | 598 | $ | 13 | $ | 561 | $ | 57 | $ | 563 | $ | 17 | |||||||||||||||||
Offsetting Assets And Liabilities [Table Text Block] | The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties and cash and non-cash collateral posted under such agreements at the end of each period were as follows: | ||||||||||||||||||||||||||||||||
28-Mar-15 | |||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Balance Sheet | |||||||||||||||||||||||||||||||||
(In Millions) | Gross Amounts Recognized | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in the Balance Sheet | Financial Instruments | Cash and Non-Cash Collateral Received or Pledged | Net Amount | |||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Derivative assets subject to master netting arrangements | $ | 818 | $ | — | $ | 818 | $ | (465 | ) | $ | (231 | ) | $ | 122 | |||||||||||||||||||
Reverse repurchase agreements | 688 | — | 688 | — | (688 | ) | — | ||||||||||||||||||||||||||
Total assets | $ | 1,506 | $ | — | $ | 1,506 | $ | (465 | ) | $ | (919 | ) | $ | 122 | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities subject to master netting arrangements | $ | 585 | $ | — | $ | 585 | $ | (465 | ) | $ | (49 | ) | $ | 71 | |||||||||||||||||||
Total liabilities | $ | 585 | $ | — | $ | 585 | $ | (465 | ) | $ | (49 | ) | $ | 71 | |||||||||||||||||||
27-Dec-14 | |||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Balance Sheet | |||||||||||||||||||||||||||||||||
(In Millions) | Gross Amounts Recognized | Gross Amounts Offset in the Balance Sheet | Net Amounts Presented in the Balance Sheet | Financial Instruments | Cash and Non-Cash Collateral Received or Pledged | Net Amount | |||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||
Derivative assets subject to master netting arrangements | $ | 559 | $ | — | $ | 559 | $ | (365 | ) | $ | (78 | ) | $ | 116 | |||||||||||||||||||
Reverse repurchase agreements | 718 | — | 718 | — | (718 | ) | — | ||||||||||||||||||||||||||
Total assets | $ | 1,277 | $ | — | $ | 1,277 | $ | (365 | ) | $ | (796 | ) | $ | 116 | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||||||
Derivative liabilities subject to master netting arrangements | $ | 559 | $ | — | $ | 559 | $ | (365 | ) | $ | (80 | ) | $ | 114 | |||||||||||||||||||
Total liabilities | $ | 559 | $ | — | $ | 559 | $ | (365 | ) | $ | (80 | ) | $ | 114 | |||||||||||||||||||
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] | The before-tax gains (losses), attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss) for each period were as follows: | ||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||||||||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||||||||||||||
Currency forwards | $ | (229 | ) | $ | 35 | ||||||||||||||||||||||||||||
Other | — | (2 | ) | ||||||||||||||||||||||||||||||
Total | $ | (229 | ) | $ | 33 | ||||||||||||||||||||||||||||
Not Designated as Hedging Instrument [Member] | |||||||||||||||||||||||||||||||||
Derivative [Line Items] | |||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block] | The effects of derivative instruments not designated as hedging instruments on the consolidated condensed statements of income for each period were as follows: | ||||||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||||||
(In Millions) | Location of Gains (Losses) | Mar 28, | Mar 29, | ||||||||||||||||||||||||||||||
Recognized in Income on Derivatives | 2015 | 2014 | |||||||||||||||||||||||||||||||
Currency forwards | Interest and other, net | $ | (18 | ) | $ | (15 | ) | ||||||||||||||||||||||||||
Currency interest rate swaps | Interest and other, net | 253 | (54 | ) | |||||||||||||||||||||||||||||
Interest rate swaps | Interest and other, net | (6 | ) | — | |||||||||||||||||||||||||||||
Total return swaps | Various | 31 | 13 | ||||||||||||||||||||||||||||||
Other | Gains (losses) on equity investments, net | (9 | ) | 1 | |||||||||||||||||||||||||||||
Total | $ | 251 | $ | (55 | ) | ||||||||||||||||||||||||||||
Goodwill_Tables
Goodwill (Tables) | 3 Months Ended | ||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||
Goodwill [Abstract] | |||||||||||||||||||||
Schedule of Goodwill [Table Text Block] | Goodwill activity for the first three months of 2015 was as follows: | ||||||||||||||||||||
(In Millions) | Dec 27, | Acquisitions | Transfers | Currency Exchange and Other | Mar 28, | ||||||||||||||||
2014 | 2015 | ||||||||||||||||||||
Client Computing Group | $ | — | $ | — | $ | 3,708 | $ | — | $ | 3,708 | |||||||||||
PC Client Group | 3,058 | — | (3,058 | ) | — | — | |||||||||||||||
Data Center Group | 2,376 | — | — | — | 2,376 | ||||||||||||||||
Internet of Things Group | 428 | — | — | — | 428 | ||||||||||||||||
Mobile and Communications Group | 650 | — | (650 | ) | — | — | |||||||||||||||
Software and services operating segments | 4,236 | — | — | (163 | ) | 4,073 | |||||||||||||||
All other | 113 | 68 | — | — | 181 | ||||||||||||||||
Total | $ | 10,861 | $ | 68 | $ | — | $ | (163 | ) | $ | 10,766 | ||||||||||
Identified_Intangible_Assets_T
Identified Intangible Assets (Tables) | 3 Months Ended | ||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |||||||||||||||||||||
Schedule Of Intangible Assets By Major Class [Table Text Block] | Identified intangible assets at the end of each period were as follows: | ||||||||||||||||||||
28-Mar-15 | |||||||||||||||||||||
(In Millions) | Gross Assets | Accumulated | Net | ||||||||||||||||||
Amortization | |||||||||||||||||||||
Acquisition-related developed technology | $ | 2,964 | $ | (2,273 | ) | $ | 691 | ||||||||||||||
Acquisition-related customer relationships | 1,644 | (1,024 | ) | 620 | |||||||||||||||||
Acquisition-related trade names | 61 | (51 | ) | 10 | |||||||||||||||||
Licensed technology and patents | 3,082 | (1,159 | ) | 1,923 | |||||||||||||||||
Identified intangible assets subject to amortization | 7,751 | (4,507 | ) | 3,244 | |||||||||||||||||
Acquisition-related trade names | 764 | — | 764 | ||||||||||||||||||
Other intangible assets | 203 | — | 203 | ||||||||||||||||||
Identified intangible assets not subject to amortization | 967 | — | 967 | ||||||||||||||||||
Total identified intangible assets | $ | 8,718 | $ | (4,507 | ) | $ | 4,211 | ||||||||||||||
December 27, 2014 | |||||||||||||||||||||
(In Millions) | Gross Assets | Accumulated | Net | ||||||||||||||||||
Amortization | |||||||||||||||||||||
Acquisition-related developed technology | $ | 3,009 | $ | (2,192 | ) | $ | 817 | ||||||||||||||
Acquisition-related customer relationships | 1,698 | (1,001 | ) | 697 | |||||||||||||||||
Acquisition-related trade names | 61 | (49 | ) | 12 | |||||||||||||||||
Licensed technology and patents | 3,153 | (1,224 | ) | 1,929 | |||||||||||||||||
Identified intangible assets subject to amortization | 7,921 | (4,466 | ) | 3,455 | |||||||||||||||||
Acquisition-related trade names | 788 | — | 788 | ||||||||||||||||||
Other intangible assets | 203 | — | 203 | ||||||||||||||||||
Identified intangible assets not subject to amortization | 991 | — | 991 | ||||||||||||||||||
Total identified intangible assets | $ | 8,912 | $ | (4,466 | ) | $ | 4,446 | ||||||||||||||
Finite-lived Intangible Assets Amortization Expense [Table Text Block] | Amortization expenses, with presentation location on the consolidated condensed statements of income, for each period were as follows: | ||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||
(In Millions) | Location | Mar 28, | Mar 29, | ||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||
Acquisition-related developed technology | Cost of sales | $ | 120 | $ | 146 | ||||||||||||||||
Acquisition-related customer relationships | Amortization of acquisition-related intangibles | 60 | 70 | ||||||||||||||||||
Acquisition-related trade names | Amortization of acquisition-related intangibles | 2 | 3 | ||||||||||||||||||
Licensed technology and patents | Cost of sales | 69 | 68 | ||||||||||||||||||
Total amortization expenses | $ | 251 | $ | 287 | |||||||||||||||||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] | Based on identified intangible assets that are subject to amortization as of March 28, 2015, we expect future amortization expenses for each period to be as follows: | ||||||||||||||||||||
(In Millions) | Remainder of 2015 | 2016 | 2017 | 2018 | 2019 | ||||||||||||||||
Acquisition-related developed technology | $ | 210 | $ | 239 | $ | 90 | $ | 69 | $ | 60 | |||||||||||
Acquisition-related customer relationships | 179 | 223 | 137 | 34 | 15 | ||||||||||||||||
Acquisition-related trade names | 7 | 3 | — | — | — | ||||||||||||||||
Licensed technology and patents | 207 | 262 | 219 | 177 | 176 | ||||||||||||||||
Total future amortization expenses | $ | 603 | $ | 727 | $ | 446 | $ | 280 | $ | 251 | |||||||||||
Other_LongTerm_Assets_Tables
Other Long-Term Assets (Tables) | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Other Assets, Noncurrent Disclosure [Abstract] | |||||||||
Schedule of Other Assets, Noncurrent [Table Text Block] | Other long-term assets at the end of each period were as follows: | ||||||||
(In Millions) | Mar 28, | Dec 27, | |||||||
2015 | 2014 | ||||||||
Equity method investments | $ | 1,574 | $ | 1,446 | |||||
Non-marketable cost method investments | 1,800 | 1,769 | |||||||
Non-current deferred tax assets | 638 | 622 | |||||||
Pre-payments for property, plant and equipment | 515 | 636 | |||||||
Loans receivable | 316 | 416 | |||||||
Other | 1,760 | 1,672 | |||||||
Total other long-term assets | $ | 6,603 | $ | 6,561 | |||||
Restructuring_and_Asset_Impair1
Restructuring and Asset Impairment Charges (Tables) | 3 Months Ended | ||||||||||||
Mar. 28, 2015 | |||||||||||||
Restructuring Costs and Asset Impairment Charges [Abstract] | |||||||||||||
Restructuring and Related Costs [Table Text Block] | Restructuring and asset impairment charges for each period were as follows: | ||||||||||||
Three Months Ended | |||||||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||||||
2015 | 2014 | ||||||||||||
Employee severance and benefit arrangements | $ | 99 | $ | 137 | |||||||||
Asset impairments and other restructuring charges | 6 | — | |||||||||||
Total restructuring and asset impairment charges | $ | 105 | $ | 137 | |||||||||
Schedule of Restructuring Reserve by Type of Cost [Table Text Block] | Restructuring and asset impairment activity for the first three months of 2015 was as follows: | ||||||||||||
(In Millions) | Employee Severance and Benefits | Asset Impairments and Other | Total | ||||||||||
Accrued restructuring balance as of December 27, 2014 | $ | 121 | $ | 11 | $ | 132 | |||||||
Additional accruals | 99 | 7 | 106 | ||||||||||
Adjustments | — | (1 | ) | (1 | ) | ||||||||
Cash payments | (82 | ) | (4 | ) | (86 | ) | |||||||
Non-cash settlements | — | (2 | ) | (2 | ) | ||||||||
Accrued restructuring balance as of March 28, 2015 | $ | 138 | $ | 11 | $ | 149 | |||||||
Deferred_Income_Tables
Deferred Income (Tables) | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Deferred Income [Abstract] | |||||||||
Deferred Revenue, by Arrangement, Disclosure [Table Text Block] | Deferred income at the end of each period was as follows: | ||||||||
(In Millions) | Mar 28, | Dec 27, | |||||||
2015 | 2014 | ||||||||
Deferred income on shipments of components to distributors | $ | 965 | $ | 944 | |||||
Deferred income from software and services | 1,231 | 1,261 | |||||||
Current deferred income | 2,196 | 2,205 | |||||||
Non-current deferred income from software and services | 428 | 483 | |||||||
Total deferred income | $ | 2,624 | $ | 2,688 | |||||
Employee_Equity_Incentive_Plan1
Employee Equity Incentive Plans (Tables) | 3 Months Ended | |||||||
Mar. 28, 2015 | ||||||||
Employee Benefits and Share-based Compensation [Abstract] | ||||||||
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] | Restricted stock unit activity in the first three months of 2015 was as follows: | |||||||
Number of | Weighted Average | |||||||
RSUs | Grant-Date | |||||||
(In Millions) | Fair Value | |||||||
December 27, 2014 | 119.4 | $ | 23.89 | |||||
Granted | 6.7 | $ | 39.05 | |||||
Vested | (3.1 | ) | $ | 27.52 | ||||
Forfeited | (1.9 | ) | $ | 23.97 | ||||
March 28, 2015 | 121.1 | $ | 24.63 | |||||
Schedule of Stock Options Roll Forward [Table Text Block] | Stock option activity in the first three months of 2015 was as follows: | |||||||
Number of | Weighted Average | |||||||
Options | Exercise Price | |||||||
(In Millions) | ||||||||
December 27, 2014 | 77.3 | $ | 21.3 | |||||
Exercised | (5.2 | ) | $ | 20.43 | ||||
Cancelled and forfeited | (0.4 | ) | $ | 23.07 | ||||
Expired | (0.1 | ) | $ | 21.97 | ||||
March 28, 2015 | 71.6 | $ | 21.35 | |||||
Options exercisable as of: | ||||||||
December 27, 2014 | 54.7 | $ | 20.29 | |||||
March 28, 2015 | 53.1 | $ | 20.41 | |||||
Gains_Losses_on_Equity_Investm1
Gains (Losses) on Equity Investments, Net (Tables) | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Gains (Losses) on Equity Investments, Net [Abstract] | |||||||||
Schedule Of Gains (Losses) On Equity Investments, Net [Table Text Block] | The components of gains (losses) on equity investments, net for each period were as follows: | ||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||
2015 | 2014 | ||||||||
Share of equity method investee losses, net | $ | (48 | ) | $ | (11 | ) | |||
Impairments | (38 | ) | (38 | ) | |||||
Gains on sales, net | 46 | 71 | |||||||
Other, net | 72 | 26 | |||||||
Total gains (losses) on equity investments, net | $ | 32 | $ | 48 | |||||
Interest_and_Other_Net_Tables
Interest and Other, Net (Tables) | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Interest and Other, Net [Abstract] | |||||||||
Interest And Other, Net [Table Text Block] | The components of interest and other, net for each period were as follows: | ||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||
2015 | 2014 | ||||||||
Interest income | $ | 32 | $ | 35 | |||||
Interest expense | (42 | ) | (37 | ) | |||||
Other, net | 36 | 114 | |||||||
Total interest and other, net | $ | 26 | $ | 112 | |||||
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Earnings Per Share [Abstract] | |||||||||
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | We computed our basic and diluted earnings per common share for each period as follows: | ||||||||
Three Months Ended | |||||||||
(In Millions, Except Per Share Amounts) | Mar 28, | Mar 29, | |||||||
2015 | 2014 | ||||||||
Net income available to common stockholders | $ | 1,992 | $ | 1,930 | |||||
Weighted average shares of common stock outstanding—basic | 4,741 | 4,974 | |||||||
Dilutive effect of employee equity incentive plans | 82 | 76 | |||||||
Dilutive effect of convertible debt | 91 | 67 | |||||||
Weighted average shares of common stock outstanding—diluted | 4,914 | 5,117 | |||||||
Basic earnings per share of common stock | $ | 0.42 | $ | 0.39 | |||||
Diluted earnings per share of common stock | $ | 0.41 | $ | 0.38 | |||||
Other_Comprehensive_Income_Los1
Other Comprehensive Income (Loss) (Tables) | 3 Months Ended | ||||||||||||||||||||||||||||
Mar. 28, 2015 | |||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | The changes in accumulated other comprehensive income (loss) by component and related tax effects in the first three months of 2015 were as follows: | ||||||||||||||||||||||||||||
(In Millions) | Unrealized Holding Gains (Losses) on Available-for-Sale Investments | Deferred Tax Asset Valuation Allowance | Unrealized Holding Gains (Losses) on Derivatives | Prior Service Credits (Costs) | Actuarial Gains (Losses) | Foreign Currency Translation Adjustment | Total | ||||||||||||||||||||||
27-Dec-14 | $ | 2,459 | $ | 26 | $ | (423 | ) | $ | (47 | ) | $ | (1,004 | ) | $ | (345 | ) | $ | 666 | |||||||||||
Other comprehensive income (loss) before reclassifications | (472 | ) | — | (229 | ) | — | 2 | (197 | ) | (896 | ) | ||||||||||||||||||
Amounts reclassified out of accumulated other comprehensive income (loss) | (54 | ) | — | 99 | 2 | 14 | — | 61 | |||||||||||||||||||||
Tax effects | 184 | (3 | ) | 41 | — | (4 | ) | 19 | 237 | ||||||||||||||||||||
Other comprehensive income (loss) | (342 | ) | (3 | ) | (89 | ) | 2 | 12 | (178 | ) | (598 | ) | |||||||||||||||||
28-Mar-15 | $ | 2,117 | $ | 23 | $ | (512 | ) | $ | (45 | ) | $ | (992 | ) | $ | (523 | ) | $ | 68 | |||||||||||
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] | The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated condensed statements of income, with presentation location, for each period were as follows: | ||||||||||||||||||||||||||||
Income Before Taxes Impact | |||||||||||||||||||||||||||||
(In Millions) | |||||||||||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||||||
Comprehensive Income Components | Mar 28, | Mar 29, | Location | ||||||||||||||||||||||||||
2015 | 2014 | ||||||||||||||||||||||||||||
Unrealized holding gains (losses) on available-for-sale investments: | |||||||||||||||||||||||||||||
$ | — | $ | 2 | Interest and other, net | |||||||||||||||||||||||||
54 | 61 | Gains (losses) on equity investments, net | |||||||||||||||||||||||||||
54 | 63 | ||||||||||||||||||||||||||||
Unrealized holding gains (losses) on derivatives: | |||||||||||||||||||||||||||||
Currency forwards | (43 | ) | 2 | Cost of sales | |||||||||||||||||||||||||
(47 | ) | 8 | Research and development | ||||||||||||||||||||||||||
(9 | ) | 2 | Marketing, general and administrative | ||||||||||||||||||||||||||
(99 | ) | 12 | |||||||||||||||||||||||||||
Amortization of pension and postretirement benefit components: | |||||||||||||||||||||||||||||
Prior service credits (costs) | (2 | ) | (1 | ) | |||||||||||||||||||||||||
Actuarial gains (losses) | (14 | ) | (10 | ) | |||||||||||||||||||||||||
(16 | ) | (11 | ) | ||||||||||||||||||||||||||
Total amounts reclassified out of accumulated other comprehensive income (loss) | $ | (61 | ) | $ | 64 | ||||||||||||||||||||||||
Operating_Segments_Information1
Operating Segments Information (Tables) | 3 Months Ended | ||||||||
Mar. 28, 2015 | |||||||||
Segment Reporting [Abstract] | |||||||||
Schedule of Segment Reporting Information, by Segment [Table Text Block] | Net revenue and operating income (loss) for each period were as follows: | ||||||||
Three Months Ended | |||||||||
(In Millions) | Mar 28, | Mar 29, | |||||||
2015 | 2014 | ||||||||
Net revenue: | |||||||||
Client Computing Group | $ | 7,420 | $ | 8,097 | |||||
Data Center Group | 3,679 | 3,087 | |||||||
Internet of Things Group | 533 | 482 | |||||||
Software and services operating segments | 534 | 553 | |||||||
All other | 615 | 545 | |||||||
Total net revenue | 12,781 | 12,764 | |||||||
Operating income (loss): | |||||||||
Client Computing Group | 1,410 | 1,847 | |||||||
Data Center Group | 1,701 | 1,336 | |||||||
Internet of Things Group | 87 | 115 | |||||||
Software and services operating segments | 3 | 8 | |||||||
All other | (586 | ) | (796 | ) | |||||
Total operating income | $ | 2,615 | $ | 2,510 | |||||
Fair_Value_Detail
Fair Value (Detail) (USD $) | 1 Months Ended | 3 Months Ended | ||
In Millions, unless otherwise specified | Jan. 31, 2011 | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | $8,010 | $9,063 | ||
Loans receivable, Fair Value Disclosure | 648 | 721 | ||
Loans receivable | 898 | 971 | ||
Non-marketable cost method investments | 1,800 | 1,769 | ||
Reverse repurchase agreements | 688 | 718 | ||
Long-term debt | 12,112 | 12,107 | ||
Loss Contingency, Cross License Annual Payment Amount Years 2014 Through 2016 | 200 | |||
Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets, Fair Value Disclosure | 23,036 | 23,708 | ||
Liabilities, Fair Value Disclosure | 611 | 580 | ||
Fair Value, Measurements, Nonrecurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fair Value, Non-Marketable Equity Investments, Gains (Losses) | -38 | -38 | ||
Carrying Amount [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Grants Receivable | 660 | 676 | ||
Loans receivable | 250 | 250 | ||
Non-marketable cost method investments | 1,800 | 1,769 | ||
Reverse repurchase agreements | 450 | 450 | ||
Short-term debt | 1,092 | 1,588 | ||
Long-term debt | 12,112 | 12,107 | ||
Carrying Amount [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notes payable | 196 | 395 | ||
Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Grants Receivable, Fair Value Disclosure | 662 | 679 | ||
Loans receivable | 250 | 250 | ||
Non-marketable cost method investments, Fair Value Disclosure | 2,690 | 2,599 | ||
Reverse repurchase agreements | 450 | 450 | ||
Short-term debt, Fair Value Disclosure | 1,734 | 2,145 | ||
Long-term debt | 12,963 | 12,776 | ||
Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notes payable, Fair Value Disclosure | 199 | 399 | ||
Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 2,498 | 2,964 | ||
Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 1,565 | 1,759 | ||
Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 3,239 | 3,516 | ||
Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 708 | 824 | ||
Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 6,549 | 7,097 | ||
Corporate Debt, Financial Institution Instruments, And Government Debt [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | 494 | |||
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | 398 | 230 | ||
Corporate Debt And Government Debt [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | 123 | |||
Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Reverse Repurchase Agreements, Fair Value Disclosure | 238 | 268 | ||
Cash Equivalents [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 742 | 48 | ||
Cash Equivalents [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 2,398 | 1,440 | ||
Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 50 | 0 | ||
Short-Term Investments [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 803 | 806 | ||
Short-Term Investments [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 602 | 1,199 | ||
Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 459 | 425 | ||
Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets, Fair Value Disclosure | 778 | 561 | ||
Loans receivable, Fair Value Disclosure | 332 | 505 | ||
Other Long-Term Investments [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 1,074 | 1,194 | ||
Other Long-Term Investments [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 452 | 508 | ||
Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 143 | 315 | ||
Other Long-Term Investments [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 6 | 6 | ||
Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets, Fair Value Disclosure | 84 | 57 | ||
Loans receivable, Fair Value Disclosure | 316 | 216 | ||
Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative liabilities, Fair Value Disclosure | 598 | 563 | ||
Other Long-Term Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative liabilities, Fair Value Disclosure | 13 | 17 | ||
Level 1 [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets, Fair Value Disclosure | 11,939 | 13,965 | ||
Liabilities, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Grants Receivable, Fair Value Disclosure | 0 | 0 | ||
Loans receivable | 0 | 0 | ||
Non-marketable cost method investments, Fair Value Disclosure | 0 | 0 | ||
Reverse repurchase agreements | 0 | 0 | ||
Short-term debt, Fair Value Disclosure | 0 | 0 | ||
Long-term debt | 10,825 | 11,467 | ||
Level 1 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notes payable, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 1,922 | 2,625 | ||
Level 1 [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 950 | 1,146 | ||
Level 1 [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 1,077 | 1,295 | ||
Level 1 [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 6,487 | 7,097 | ||
Level 1 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Reverse Repurchase Agreements, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Cash Equivalents [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Cash Equivalents [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 226 | 321 | ||
Level 1 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Short-Term Investments [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 262 | 363 | ||
Level 1 [Member] | Short-Term Investments [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 100 | 149 | ||
Level 1 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 108 | 252 | ||
Level 1 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets, Fair Value Disclosure | 0 | 0 | ||
Loans receivable, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Other Long-Term Investments [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 542 | 453 | ||
Level 1 [Member] | Other Long-Term Investments [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 197 | 189 | ||
Level 1 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 68 | 75 | ||
Level 1 [Member] | Other Long-Term Investments [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets, Fair Value Disclosure | 0 | 0 | ||
Loans receivable, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative liabilities, Fair Value Disclosure | 0 | 0 | ||
Level 1 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative liabilities, Fair Value Disclosure | 0 | 0 | ||
Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets, Fair Value Disclosure | 10,928 | 9,613 | ||
Liabilities, Fair Value Disclosure | 609 | 580 | ||
Level 2 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Grants Receivable, Fair Value Disclosure | 662 | 679 | ||
Loans receivable | 250 | 250 | ||
Non-marketable cost method investments, Fair Value Disclosure | 0 | 0 | ||
Reverse repurchase agreements | 450 | 450 | ||
Short-term debt, Fair Value Disclosure | 1,734 | 2,145 | ||
Long-term debt | 2,138 | 1,309 | ||
Level 2 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notes payable, Fair Value Disclosure | 199 | 399 | ||
Level 2 [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 576 | 339 | ||
Level 2 [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 615 | 613 | ||
Level 2 [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 2,162 | 2,221 | ||
Level 2 [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 668 | 766 | ||
Level 2 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 2 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Reverse Repurchase Agreements, Fair Value Disclosure | 238 | 268 | ||
Level 2 [Member] | Cash Equivalents [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 742 | 48 | ||
Level 2 [Member] | Cash Equivalents [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 2,172 | 1,119 | ||
Level 2 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 50 | 0 | ||
Level 2 [Member] | Short-Term Investments [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 509 | 412 | ||
Level 2 [Member] | Short-Term Investments [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 502 | 1,050 | ||
Level 2 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 351 | 173 | ||
Level 2 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets, Fair Value Disclosure | 776 | 559 | ||
Loans receivable, Fair Value Disclosure | 332 | 505 | ||
Level 2 [Member] | Other Long-Term Investments [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 519 | 728 | ||
Level 2 [Member] | Other Long-Term Investments [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 255 | 319 | ||
Level 2 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 75 | 240 | ||
Level 2 [Member] | Other Long-Term Investments [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 2 | 2 | ||
Level 2 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets, Fair Value Disclosure | 68 | 35 | ||
Loans receivable, Fair Value Disclosure | 316 | 216 | ||
Level 2 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative liabilities, Fair Value Disclosure | 596 | 563 | ||
Level 2 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative liabilities, Fair Value Disclosure | 13 | 17 | ||
Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Assets, Fair Value Disclosure | 169 | 130 | ||
Liabilities, Fair Value Disclosure | 2 | 0 | ||
Level 3 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Grants Receivable, Fair Value Disclosure | 0 | 0 | ||
Loans receivable | 0 | 0 | ||
Non-marketable cost method investments, Fair Value Disclosure | 2,690 | 2,599 | ||
Reverse repurchase agreements | 0 | 0 | ||
Short-term debt, Fair Value Disclosure | 0 | 0 | ||
Long-term debt | 0 | 0 | ||
Level 3 [Member] | Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Notes payable, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Trading assets, Fair Value Disclosure | 40 | 58 | ||
Level 3 [Member] | Marketable Equity Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 62 | 0 | ||
Level 3 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Reverse Repurchase Agreements, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Cash Equivalents [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Cash Equivalents [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Cash Equivalents [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Short-Term Investments [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 32 | 31 | ||
Level 3 [Member] | Short-Term Investments [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Short-Term Investments [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets, Fair Value Disclosure | 2 | 2 | ||
Loans receivable, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Other Long-Term Investments [Member] | Corporate Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 13 | 13 | ||
Level 3 [Member] | Other Long-Term Investments [Member] | Financial Institution Instruments [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Other Long-Term Investments [Member] | Government Debt [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Other Long-Term Investments [Member] | Asset-Backed Securities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Investments, Fair Value Disclosure | 4 | 4 | ||
Level 3 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative assets, Fair Value Disclosure | 16 | 22 | ||
Loans receivable, Fair Value Disclosure | 0 | 0 | ||
Level 3 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative liabilities, Fair Value Disclosure | 2 | 0 | ||
Level 3 [Member] | Other Long-Term Liabilities [Member] | Fair Value, Measurements, Recurring [Member] | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Derivative liabilities, Fair Value Disclosure | $0 | $0 |
Cash_and_Investments_Detail
Cash and Investments (Detail) (USD $) | Mar. 28, 2015 | Dec. 27, 2014 |
In Millions, unless otherwise specified | ||
Investments and Cash [Abstract] | ||
Available-for-sale investments | $13,278 | $13,038 |
Cash | 816 | 805 |
Equity method investments | 1,574 | 1,446 |
Loans receivable | 898 | 971 |
Non-marketable cost method investments | 1,800 | 1,769 |
Reverse repurchase agreements | 688 | 718 |
Trading assets | 8,010 | 9,063 |
Total cash and investments | $27,064 | $27,810 |
Cash_and_Investments_Available
Cash and Investments, Available-for-Sale Investments (Detail) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 |
Available-for-sale Securities [Abstract] | |||
Adjusted Cost | $6,720 | ||
Fair Value | 6,729 | ||
Adjusted Cost, Total | 10,020 | 9,253 | |
Gross Unrealized Gains, Total | 3,272 | 3,794 | |
Gross Unrealized Losses, Total | -14 | -9 | |
Fair Value, Total | 13,278 | 13,038 | |
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds | 43 | 279 | |
Available-for-sale Securities, Gross Realized Gains | 43 | 67 | |
Due in 1 year or less, Cost | 4,697 | ||
Due in 1-2 years, Cost | 864 | ||
Due in 2-5 years, Cost | 779 | ||
Instruments not due at a single maturity date, Cost | 380 | ||
Due in 1 year or less, Fair Value | 4,707 | ||
Due in 1-2 years, Fair Value | 865 | ||
Due in 2-5 years, Fair Value | 778 | ||
Instruments not due at a single maturity date, Fair Value | 379 | ||
Cash and Cash Equivalents [Member] | |||
Available-for-sale Securities [Abstract] | |||
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds | 0 | 105 | |
Asset-Backed Securities [Member] | |||
Available-for-sale Securities [Abstract] | |||
Adjusted Cost | 8 | 8 | |
Gross Unrealized Gains | 0 | 0 | |
Gross Unrealized Losses | -2 | -2 | |
Fair Value | 6 | 6 | |
Corporate Debt [Member] | |||
Available-for-sale Securities [Abstract] | |||
Adjusted Cost | 2,609 | 2,040 | |
Gross Unrealized Gains | 15 | 13 | |
Gross Unrealized Losses | -5 | -5 | |
Fair Value | 2,619 | 2,048 | |
Financial Institution Instruments [Member] | |||
Available-for-sale Securities [Abstract] | |||
Adjusted Cost | 3,452 | 3,146 | |
Gross Unrealized Gains | 1 | 2 | |
Gross Unrealized Losses | -1 | -1 | |
Fair Value | 3,452 | 3,147 | |
Government Debt [Member] | |||
Available-for-sale Securities [Abstract] | |||
Adjusted Cost | 651 | 741 | |
Gross Unrealized Gains | 1 | 0 | |
Gross Unrealized Losses | 0 | -1 | |
Fair Value | 652 | 740 | |
Marketable Equity Securities [Member] | |||
Available-for-sale Securities [Abstract] | |||
Adjusted Cost | 3,300 | 3,318 | |
Gross Unrealized Gains | 3,255 | 3,779 | |
Gross Unrealized Losses | -6 | 0 | |
Fair Value | $6,549 | $7,097 |
Cash_and_Investments_Equity_Me
Cash and Investments, Equity Method Investments (Detail) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 |
Schedule of Equity Method Investments [Line Items] | |||
Carrying Value | $1,574 | $1,446 | |
Cost Method Investments | 1,800 | 1,769 | |
IM Flash Technologies, LLC [Member] | |||
Schedule of Equity Method Investments [Line Items] | |||
Ownership Percentage | 49.00% | ||
Carrying Value | 786 | 713 | |
Variable Interest Entity, Reporting Entity Involvement, Known Maximum Loss Exposure, Amount | 786 | ||
Percentage Of Purchase Commitment Of Production Output And Production Related Services | 49.00% | ||
Related Party Transactions [Abstract] | |||
Related Party Transaction, Purchases from Related Party | 95 | 105 | |
Due to Related Parties | 20 | 60 | |
Cloudera, Inc. [Member] | |||
Schedule of Equity Method Investments [Line Items] | |||
Ownership Percentage | 17.00% | ||
Carrying Value | 278 | 280 | |
Cost Method Investments | $454 | $454 |
Cash_and_Investments_Trading_A
Cash and Investments, Trading Assets (Detail) (Debt Securities [Member], USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Debt Securities [Member] | ||
Schedule Of Trading Securities And Other Trading Assets [Line Items] | ||
Trading Securities, Change in Unrealized Holding Gain (Loss) | ($200) | $79 |
Net gains (losses) on derivatives related to trading securities | $194 | ($82) |
Inventories_Detail
Inventories (Detail) (USD $) | Mar. 28, 2015 | Dec. 27, 2014 |
In Millions, unless otherwise specified | ||
Inventory, Net, Items Net of Reserve Alternative [Abstract] | ||
Raw materials | $528 | $462 |
Work in process | 2,190 | 2,375 |
Finished goods | 1,700 | 1,436 |
Total inventories | $4,418 | $4,273 |
Derivative_Financial_Instrumen2
Derivative Financial Instruments (Detail) | 3 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | 3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Dec. 27, 2014 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 | Mar. 28, 2015 | Mar. 29, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 | Mar. 28, 2015 | Dec. 27, 2014 |
USD ($) | USD ($) | USD ($) | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Subject To Regulatory Approvals And Other Closing Conditions Of A Series Of Agreements With Counterparty [Member] | Subject To Regulatory Approvals And Other Closing Conditions Of A Series Of Agreements With Counterparty [Member] | British Pound Sterling [Member] | British Pound Sterling [Member] | British Pound Sterling [Member] | Chinese Yuan [Member] | Chinese Yuan [Member] | Chinese Yuan [Member] | Euro [Member] | Euro [Member] | Euro [Member] | Indian Rupee [Member] | Indian Rupee [Member] | Indian Rupee [Member] | Israeli Shekel [Member] | Israeli Shekel [Member] | Israeli Shekel [Member] | Japanese Yen [Member] | Japanese Yen [Member] | Japanese Yen [Member] | Malaysian Ringgit [Member] | Malaysian Ringgit [Member] | Malaysian Ringgit [Member] | Swiss Franc [Member] | Swiss Franc [Member] | Swiss Franc [Member] | Other Currencies [Member] | Other Currencies [Member] | Other Currencies [Member] | Total Currency Exchange Rate Derivatives [Member] | Total Currency Exchange Rate Derivatives [Member] | Total Currency Exchange Rate Derivatives [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Forwards [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Currency Interest Rate Swaps [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Embedded Debt Derivatives [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Interest Rate Swaps [Member] | Total Return Swaps [Member] | Total Return Swaps [Member] | Total Return Swaps [Member] | Total Return Swaps [Member] | Total Return Swaps [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | Other Derivative Instruments [Member] | |
USD ($) | USD ($) | USD ($) | USD ($) | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | USD ($) | USD ($) | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | USD ($) | USD ($) | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | USD ($) | USD ($) | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Tsinghua Unigroup Ltd. [Member] | Tsinghua Unigroup Ltd. [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | Tsinghua Unigroup Ltd. [Member] | USD ($) | USD ($) | USD ($) | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | USD ($) | USD ($) | USD ($) | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | USD ($) | USD ($) | USD ($) | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | USD ($) | USD ($) | USD ($) | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | USD ($) | USD ($) | USD ($) | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Other Current Assets [Member] | Other Current Assets [Member] | Other Long-Term Assets [Member] | Other Long-Term Assets [Member] | Other Accrued Liabilities [Member] | Other Accrued Liabilities [Member] | Other Long-Term Liabilities [Member] | Other Long-Term Liabilities [Member] | ||||
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | CNY | Interest and Other, Net [Member] | Interest and Other, Net [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | USD ($) | Interest and Other, Net [Member] | Interest and Other, Net [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Interest and Other, Net [Member] | Interest and Other, Net [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Various [Member] | Various [Member] | Gains (losses) on equity investments, net [Member] | Gains (losses) on equity investments, net [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gross Notional Amounts [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative, Notional Amount | $27,192 | $22,484 | $27,076 | $314 | $410 | $487 | $4,079 | $3,097 | $1,291 | $7,332 | $7,486 | $6,199 | $420 | $418 | $252 | $2,010 | $2,489 | $1,878 | $4,206 | $3,779 | $3,542 | $827 | $902 | $524 | $1,146 | $1,289 | $1,256 | $952 | $1,154 | $1,095 | $21,286 | $21,024 | $16,524 | $16,192 | $11,729 | $15,578 | $1,500 | $5,094 | $5,446 | $4,795 | $3,600 | $3,600 | $3,600 | $1,128 | $1,347 | $1,311 | $1,106 | $1,056 | $989 | $72 | $60 | $49 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tsinghua Unigroup Ltd. Agreement [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cost Method Investments | 1,800 | 1,769 | 1,500 | 9,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cost Method Investment, Ownership Percentage | 20.00% | 20.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Recognized | 818 | 559 | 778 | 561 | 12 | 6 | 766 | 555 | 84 | 57 | 3 | 1 | 81 | 56 | 12 | 6 | 253 | 207 | 3 | 1 | 0 | 0 | 510 | 344 | 65 | 34 | 0 | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 2 | 1 | 16 | 22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Recognized | 585 | 559 | 598 | 563 | 483 | 497 | 115 | 66 | 13 | 17 | 5 | 9 | 8 | 8 | 483 | 497 | 87 | 44 | 5 | 9 | 0 | 0 | 12 | 7 | 0 | 0 | 1 | 4 | 8 | 8 | 13 | 11 | 0 | 0 | 2 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting Derivative Assets [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Assets Subject To Master Netting Arrangements, Net Amounts Presented In The Balance Sheet | 818 | 559 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments | -465 | -365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Not Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged | -231 | -78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Assets Subject To Master Netting Arrangements, Net Amount | 122 | 116 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reverse Repurchase Agreements, Gross Amounts Recognized | 688 | 718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reverse Repurchase Agreements, Gross Amounts Offset In The Balance Sheet | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reverse Repurchase Agreements, Net Amounts Presented In The Balance Sheet | 688 | 718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reverse Repurchase Agreements, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reverse Repurchase Agreements, Gross Amounts Not Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged | -688 | -718 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reverse Repurchase Agreements, Net Amount | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Assets, Gross Amounts Recognized | 1,506 | 1,277 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Assets, Gross Amounts Offset In The Balance Sheet | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Assets, Net Amounts Presented In The Balance Sheet | 1,506 | 1,277 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Assets, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments | -465 | -365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Assets, Gross Amounts Not Offset In The Balance Sheet - Cash and Non-Cash Collateral Received Or Pledged | -919 | -796 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Assets, Net Amount | 122 | 116 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting Derivative Liabilities [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liabilities Subject To Master Netting Arrangements, Net Amounts Presented In The Balance Sheet | 585 | 559 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet - Financial Instruments | -465 | -365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged | -49 | -80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liabilities Subject To Master Netting Arrangements, Net Amount | 71 | 114 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Liabilities, Gross Amounts Recognized | 585 | 559 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Liabilities, Gross Amounts Offset In The Balance Sheet | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Liabilities, Net Amounts Presented In The Balance Sheet | 585 | 559 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Liabilities, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments | -465 | -365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Liabilities, Gross Amounts Not Offset In The Balance Sheet - Cash and Non-Cash Collateral Received Or Pledged | -49 | -80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Liabilities, Net Amount | 71 | 114 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments in Cash Flow Hedging Relationships [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion) | -229 | 33 | -229 | 35 | 0 | -2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments Not Designated as Hedging Instruments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gains (Losses) Recognized in Income On Derivatives | $251 | ($55) | ($18) | ($15) | $253 | ($54) | ($6) | $0 | $31 | $13 | ($9) | $1 |
Acquisitions_Detail
Acquisitions (Detail) (Series of Individually Immaterial Business Acquisitions [Member], USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 28, 2015 |
Series of Individually Immaterial Business Acquisitions [Member] | |
Business Acquisition [Line Items] | |
Business Combinations During Period, Consideration Transferred | $68 |
Goodwill_Detail
Goodwill (Detail) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Mar. 28, 2015 |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | $10,861 |
Goodwill, Acquisitions | 68 |
Goodwill, Transfers | 0 |
Goodwill, Currency Exchange and Other | -163 |
Goodwill, Ending Balance | 10,766 |
Client Computing Group [Member] | |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | 0 |
Goodwill, Acquisitions | 0 |
Goodwill, Transfers | 3,708 |
Goodwill, Currency Exchange and Other | 0 |
Goodwill, Ending Balance | 3,708 |
PC Client Group [Member] | |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | 3,058 |
Goodwill, Acquisitions | 0 |
Goodwill, Transfers | -3,058 |
Goodwill, Currency Exchange and Other | 0 |
Goodwill, Ending Balance | 0 |
Data Center Group [Member] | |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | 2,376 |
Goodwill, Acquisitions | 0 |
Goodwill, Transfers | 0 |
Goodwill, Currency Exchange and Other | 0 |
Goodwill, Ending Balance | 2,376 |
Internet of Things Group [Member] | |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | 428 |
Goodwill, Acquisitions | 0 |
Goodwill, Transfers | 0 |
Goodwill, Currency Exchange and Other | 0 |
Goodwill, Ending Balance | 428 |
Mobile and Communications Group [Member] | |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | 650 |
Goodwill, Acquisitions | 0 |
Goodwill, Transfers | -650 |
Goodwill, Currency Exchange and Other | 0 |
Goodwill, Ending Balance | 0 |
Software and services operating segments [Member] | |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | 4,236 |
Goodwill, Acquisitions | 0 |
Goodwill, Transfers | 0 |
Goodwill, Currency Exchange and Other | -163 |
Goodwill, Ending Balance | 4,073 |
All other [Member] | |
Goodwill [Roll Forward] | |
Goodwill, Beginning Balance | 113 |
Goodwill, Acquisitions | 68 |
Goodwill, Transfers | 0 |
Goodwill, Currency Exchange and Other | 0 |
Goodwill, Ending Balance | $181 |
Identified_Intangible_Assets_F
Identified Intangible Assets, Finite-Lived Intangible Assets (Detail) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 |
Identified Intangible Assets By Major Class [Abstract] | |||
Gross Assets, Subject to Amortization | $7,751 | $7,921 | |
Accumulated Amortization | -4,507 | -4,466 | |
Net | 3,244 | 3,455 | |
Identified Intangible Assets, Amortization Expenses [Abstract] | |||
Amortization of intangibles | 251 | 287 | |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | |||
Future Amortization Expense, Remainder of 2015 | 603 | ||
Future Amortization Expense, 2016 | 727 | ||
Future Amortization Expense, 2017 | 446 | ||
Future Amortization Expense, 2018 | 280 | ||
Future Amortization Expense, 2019 | 251 | ||
Acquisition-related Developed Technology [Member] | |||
Identified Intangible Assets By Major Class [Abstract] | |||
Gross Assets, Subject to Amortization | 2,964 | 3,009 | |
Accumulated Amortization | -2,273 | -2,192 | |
Net | 691 | 817 | |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | |||
Future Amortization Expense, Remainder of 2015 | 210 | ||
Future Amortization Expense, 2016 | 239 | ||
Future Amortization Expense, 2017 | 90 | ||
Future Amortization Expense, 2018 | 69 | ||
Future Amortization Expense, 2019 | 60 | ||
Acquisition-related Developed Technology [Member] | Cost of sales [Member] | |||
Identified Intangible Assets, Amortization Expenses [Abstract] | |||
Amortization of intangibles | 120 | 146 | |
Acquisition-related Customer Relationships [Member] | |||
Identified Intangible Assets By Major Class [Abstract] | |||
Gross Assets, Subject to Amortization | 1,644 | 1,698 | |
Accumulated Amortization | -1,024 | -1,001 | |
Net | 620 | 697 | |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | |||
Future Amortization Expense, Remainder of 2015 | 179 | ||
Future Amortization Expense, 2016 | 223 | ||
Future Amortization Expense, 2017 | 137 | ||
Future Amortization Expense, 2018 | 34 | ||
Future Amortization Expense, 2019 | 15 | ||
Acquisition-related Customer Relationships [Member] | Amortization of acquisition-related intangibles [Member] | |||
Identified Intangible Assets, Amortization Expenses [Abstract] | |||
Amortization of intangibles | 60 | 70 | |
Acquisition-related Trade Names [Member] | |||
Identified Intangible Assets By Major Class [Abstract] | |||
Gross Assets, Subject to Amortization | 61 | 61 | |
Accumulated Amortization | -51 | -49 | |
Net | 10 | 12 | |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | |||
Future Amortization Expense, Remainder of 2015 | 7 | ||
Future Amortization Expense, 2016 | 3 | ||
Future Amortization Expense, 2017 | 0 | ||
Future Amortization Expense, 2018 | 0 | ||
Future Amortization Expense, 2019 | 0 | ||
Acquisition-related Trade Names [Member] | Amortization of acquisition-related intangibles [Member] | |||
Identified Intangible Assets, Amortization Expenses [Abstract] | |||
Amortization of intangibles | 2 | 3 | |
Licensed Technology and Patents [Member] | |||
Identified Intangible Assets By Major Class [Abstract] | |||
Gross Assets, Subject to Amortization | 3,082 | 3,153 | |
Accumulated Amortization | -1,159 | -1,224 | |
Net | 1,923 | 1,929 | |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | |||
Future Amortization Expense, Remainder of 2015 | 207 | ||
Future Amortization Expense, 2016 | 262 | ||
Future Amortization Expense, 2017 | 219 | ||
Future Amortization Expense, 2018 | 177 | ||
Future Amortization Expense, 2019 | 176 | ||
Licensed Technology and Patents [Member] | Cost of sales [Member] | |||
Identified Intangible Assets, Amortization Expenses [Abstract] | |||
Amortization of intangibles | $69 | $68 |
Identified_Intangible_Assets_I
Identified Intangible Assets, Indefinite-Lived Intangible Asset (Detail) (USD $) | Mar. 28, 2015 | Dec. 27, 2014 |
In Millions, unless otherwise specified | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Gross Assets, Not Subject to Amortization | $967 | $991 |
Acquisition-related Trade Names [Member] | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Gross Assets, Not Subject to Amortization | 764 | 788 |
Other Intangible Assets [Member] | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Gross Assets, Not Subject to Amortization | $203 | $203 |
Identified_Intangible_Assets_T1
Identified Intangible Assets, Total Intangible Assets (Detail) (USD $) | Mar. 28, 2015 | Dec. 27, 2014 |
In Millions, unless otherwise specified | ||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ||
Identified intangible assets, gross | $8,718 | $8,912 |
Identified intangible assets, net | $4,211 | $4,446 |
Other_LongTerm_Assets_Detail
Other Long-Term Assets (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Dec. 27, 2014 |
Other Assets, Noncurrent Disclosure [Abstract] | ||
Equity method investments | $1,574 | $1,446 |
Non-marketable cost method investments | 1,800 | 1,769 |
Non-current deferred tax assets | 638 | 622 |
Pre-payments for property, plant and equipment | 515 | 636 |
Loans receivable | 316 | 416 |
Other | 1,760 | 1,672 |
Total other long-term assets | 6,603 | 6,561 |
Transfers From Other Long-Term Assets to Property, Plant, And Equipment Related To Prepaid Equipment | $179 |
Restructuring_and_Asset_Impair2
Restructuring and Asset Impairment Charges (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Employee | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and Related Activities, Completion Date | 26-Dec-15 | |
Restructuring and Related Cost, Incurred Cost | $105 | $137 |
Restructuring and Related Cost, Number of Positions Eliminated | 1,400 | |
Restructuring and Related Cost, Cost Incurred to Date | 640 | |
Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date | 9,000 | |
Restructuring Reserve [Roll Forward] | ||
Accrued restructuring, Beginning Balance | 132 | |
Accrued restructuring, Additional accruals | 106 | |
Accrued restructuring, Adjustments | -1 | |
Accrued restructuring, Cash payments | -86 | |
Accrued restructuring, Non-cash settlements | -2 | |
Accrued restructuring, Ending Balance | 149 | |
Employee severance and benefit arrangements [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and Related Cost, Incurred Cost | 99 | 137 |
Restructuring and Related Cost, Cost Incurred to Date | 565 | |
Restructuring Reserve [Roll Forward] | ||
Accrued restructuring, Beginning Balance | 121 | |
Accrued restructuring, Additional accruals | 99 | |
Accrued restructuring, Adjustments | 0 | |
Accrued restructuring, Cash payments | -82 | |
Accrued restructuring, Non-cash settlements | 0 | |
Accrued restructuring, Ending Balance | 138 | |
Asset Impairments and other restructuring charges [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and Related Cost, Incurred Cost | 6 | 0 |
Restructuring and Related Cost, Cost Incurred to Date | 75 | |
Restructuring Reserve [Roll Forward] | ||
Accrued restructuring, Beginning Balance | 11 | |
Accrued restructuring, Additional accruals | 7 | |
Accrued restructuring, Adjustments | -1 | |
Accrued restructuring, Cash payments | -4 | |
Accrued restructuring, Non-cash settlements | -2 | |
Accrued restructuring, Ending Balance | $11 |
Deferred_Income_Detail
Deferred Income (Detail) (USD $) | Mar. 28, 2015 | Dec. 27, 2014 |
In Millions, unless otherwise specified | ||
Deferred Revenue Arrangement [Line Items] | ||
Current deferred income | $2,196 | $2,205 |
Total deferred income | 2,624 | 2,688 |
Shipments of components to distributors [Member] | ||
Deferred Revenue Arrangement [Line Items] | ||
Current deferred income | 965 | 944 |
Software and services [Member] | ||
Deferred Revenue Arrangement [Line Items] | ||
Current deferred income | 1,231 | 1,261 |
Non-current deferred income | $428 | $483 |
Employee_Equity_Incentive_Plan2
Employee Equity Incentive Plans (Detail) (USD $) | 3 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 |
Employee Equity Incentive Plans, (Textual) (Details) [Abstract] | |||
Share-based Compensation | $368 | $283 | |
Restricted Stock Units (RSUs) [Member] | |||
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units [Roll Forward] | |||
Number of RSUs outstanding, beginning balance | 119.4 | ||
Number of RSUs granted | 6.7 | ||
Number of RSUs vested | -3.1 | ||
Number of RSUs forfeited | -1.9 | ||
Number of RSUs outstanding, ending balance | 121.1 | ||
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units, Weighted Average Exercise Price [Roll Forward] | |||
Weighted-average grant date fair value of RSU balance (in dollars per share) | $24.63 | $23.89 | |
Weighted-average grant date fair value of granted RSUs (in dollars per share) | $39.05 | ||
Weighted-average grant date fair value of vested RSUs (in dollars per share) | $27.52 | ||
Weighted-average grant date fair value of forfeited RSUs (in dollars per share) | $23.97 | ||
Stock Option Awards [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | |||
Number of options outstanding, beginning balance | 77.3 | ||
Number of options exercised | -5.2 | ||
Number of options cancelled and forfeited | -0.4 | ||
Number of options expired | -0.1 | ||
Number of options outstanding, ending balance | 71.6 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] | |||
Weighted-average exercise price of stock options (in dollars per share) | $21.35 | $21.30 | |
Weighted-average exercise price for stock options exercised (in dollars per share) | $20.43 | ||
Weighted-average exercise price for stock options cancelled and forfeited (in dollars per share) | $23.07 | ||
Weighted-average exercise price for stock options expired (in dollars per share) | $21.97 | ||
Number of options exercisable | 53.1 | 54.7 | |
Weighted-average exercise price for options exercisable (in dollars per share) | $20.41 | $20.29 | |
Market Based Restricted Stock Units [Member] | |||
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units [Roll Forward] | |||
Number of RSUs outstanding, ending balance | 4.8 | ||
2006 Equity Incentive Plan [Member] | |||
Employee Equity Incentive Plans, (Textual) (Details) [Abstract] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 254 | ||
2006 Stock Purchase Plan [Member] | |||
Employee Equity Incentive Plans, (Textual) (Details) [Abstract] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 189 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent | 85.00% | ||
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | 8.1 | 10.7 | |
Employee Purchases, Amount | $234 | $212 |
Common_Stock_Repurchases_Detai
Common Stock Repurchases (Detail) (USD $) | 3 Months Ended | 12 Months Ended | |
Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 | |
Common Stock Repurchases [Line Items] | |||
Collateral Associated With Repurchase Of Common Stock | ($325,000,000) | $0 | $325,000,000 |
Common Stock Repurchase Program [Member] | |||
Common Stock Repurchases [Line Items] | |||
Stock Repurchase Program, Authorized Amount | 65,000,000,000 | ||
Stock Repurchase Program, Remaining Authorized Repurchase Amount | 11,600,000,000 | ||
Stock Repurchased During Period, Shares | 21,300,000 | ||
Stock Repurchased During Period, Value | 750,000,000 | ||
Stock Repurchased and Retired During Period, Shares | 22,100,000 | ||
Stock Repurchased and Retired During Period, Value | 545,000,000 | ||
Accumulated Stock Repurchased During Program, Total Shares | 4,700,000,000 | ||
Accumulated Stock Repurchased During Program, Total Value | $103,000,000,000 |
Gains_Losses_on_Equity_Investm2
Gains (Losses) on Equity Investments, Net (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Schedule Of Investment Type [Line Items] | ||
Share of equity method investee losses, net | ($48) | ($11) |
Impairments | -38 | -38 |
Other, net | 72 | 26 |
Total gains (losses) on equity investments, net | 32 | 48 |
Equity Investments [Member] | ||
Schedule Of Investment Type [Line Items] | ||
Gains on sales, net | $46 | $71 |
Interest_and_Other_Net_Detail
Interest and Other, Net (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Interest and Other, Net [Abstract] | ||
Interest income | $32 | $35 |
Interest expense | -42 | -37 |
Other, net | 36 | 114 |
Total interest and other, net | 26 | 112 |
Interest Costs Capitalized | $81 | $77 |
Earnings_Per_Share_Detail
Earnings Per Share (Detail) (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Earnings Per Share [Abstract] | ||
Net income available to common stockholders | $1,992 | $1,930 |
Weighted average shares of common stock outstanding—basic | 4,741 | 4,974 |
Dilutive effect of employee equity incentive plans (shares) | 82 | 76 |
Dilutive effect of convertible debt (shares) | 91 | 67 |
Weighted average shares of common stock outstanding—diluted | 4,914 | 5,117 |
Basic earnings per share of common stock (in dollars per share) | $0.42 | $0.39 |
Diluted earnings per share of common stock (in dollars per share) | $0.41 | $0.38 |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (shares) | 3 | 33 |
Other_Comprehensive_Income_Los2
Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 | Dec. 27, 2014 |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Accumulated Other Comprehensive Income (Loss), Total | $68 | $666 | |
Other comprehensive income (loss) before reclassifications | -896 | ||
Amounts reclassified out of accumulated other comprehensive income (loss) | 61 | ||
Tax effects | 237 | ||
Other comprehensive income (loss) | -598 | -87 | |
Unrealized holding gains (losses) on available-for-sale investments [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Accumulated Other Comprehensive Income (Loss), Unrealized Holding Gains (Losses) On Available-for-Sale Investments | 2,117 | 2,459 | |
Other comprehensive income (loss) before reclassifications | -472 | ||
Amounts reclassified out of accumulated other comprehensive income (loss) | -54 | ||
Tax effects | 184 | ||
Other comprehensive income (loss) | -342 | ||
Deferred tax asset valuation allowance [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Accumulated Other Comprehensive Income (Loss), Deferred Tax Asset Valuation Allowance | 23 | 26 | |
Other comprehensive income (loss) before reclassifications | 0 | ||
Amounts reclassified out of accumulated other comprehensive income (loss) | 0 | ||
Tax effects | -3 | ||
Other comprehensive income (loss) | -3 | ||
Unrealized holding gains (losses) on derivatives [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Accumulated Other Comprehensive Income (Loss), Unrealized Holding Gains (Losses) On Derivatives | -512 | -423 | |
Other comprehensive income (loss) before reclassifications | -229 | ||
Amounts reclassified out of accumulated other comprehensive income (loss) | 99 | ||
Tax effects | 41 | ||
Other comprehensive income (loss) | -89 | ||
Prior service credits (costs) [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Accumulated Other Comprehensive Income (Loss), Prior Service Credits (Costs) | -45 | -47 | |
Other comprehensive income (loss) before reclassifications | 0 | ||
Amounts reclassified out of accumulated other comprehensive income (loss) | 2 | ||
Tax effects | 0 | ||
Other comprehensive income (loss) | 2 | ||
Actuarial gains (losses) [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Accumulated Other Comprehensive Income (Loss), Actuarial Gains (Losses) | -992 | -1,004 | |
Other comprehensive income (loss) before reclassifications | 2 | ||
Amounts reclassified out of accumulated other comprehensive income (loss) | 14 | ||
Tax effects | -4 | ||
Other comprehensive income (loss) | 12 | ||
Foreign currency translation adjustment [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment | -523 | -345 | |
Other comprehensive income (loss) before reclassifications | -197 | ||
Amounts reclassified out of accumulated other comprehensive income (loss) | 0 | ||
Tax effects | 19 | ||
Other comprehensive income (loss) | ($178) |
Other_Comprehensive_Income_Los3
Other Comprehensive Income (Loss), Reclassification out of Accumulated Other Comprehensive Income (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||
Interest and other, net | $26 | $112 |
Gains (losses) on equity investments, net | 32 | 48 |
Income before taxes | 2,673 | 2,670 |
Cost of sales | -5,051 | -5,151 |
Research and development | -2,995 | -2,846 |
Marketing, general and administrative | -1,953 | -2,047 |
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | -409 | |
Reclassified out of Accumulated Other Comprehensive Income (Loss) [Member] | ||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||
Income before taxes | -61 | 64 |
Unrealized holding gains (losses) on available-for-sale investments [Member] | Reclassified out of Accumulated Other Comprehensive Income (Loss) [Member] | ||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||
Interest and other, net | 0 | 2 |
Gains (losses) on equity investments, net | 54 | 61 |
Income before taxes | 54 | 63 |
Unrealized holding gains (losses) on derivatives [Member] | Reclassified out of Accumulated Other Comprehensive Income (Loss) [Member] | ||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||
Income before taxes | -99 | 12 |
Unrealized holding gains (losses) on derivatives [Member] | Reclassified out of Accumulated Other Comprehensive Income (Loss) [Member] | Currency Forwards [Member] | ||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||
Cost of sales | -43 | 2 |
Research and development | -47 | 8 |
Marketing, general and administrative | -9 | 2 |
Prior service credits (costs) [Member] | ||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||
Reclassified out of Accumulated Other Comprehensive Income (Loss), Prior Service (Credits) Costs | -2 | -1 |
Actuarial gains (losses) [Member] | ||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||
Reclassified out of Accumulated Other Comprehensive Income (Loss), Actuarial Gains (Losses) | -14 | -10 |
Amortization of pension and postretirement benefit components [Member] | Reclassified out of Accumulated Other Comprehensive Income (Loss) [Member] | ||
Reclassification out of Accumulated Other Comprehensive Income [Line Items] | ||
Income before taxes | ($16) | ($11) |
Contingencies_Detail
Contingencies (Detail) | Aug. 19, 2010 | Jun. 30, 2012 | 31-May-09 | 31-May-09 | Dec. 31, 2008 | Jan. 31, 2015 | 31-May-13 | Mar. 28, 2015 | 31-May-13 |
Share data in Millions, except Per Share data, unless otherwise specified | McAfee, Inc. [Member] | McAfee, Inc. [Member] | EC Fine [Member] | EC Fine [Member] | Lehman Matter [Member] | Lehman Matter [Member] | Lehman Matter [Member] | Lehman Matter [Member] | London Interbank Offered Rate (LIBOR) [Member] |
McAfee Shareholder Litigation [Member] | McAfee Shareholder Litigation [Member] | USD ($) | EUR (€) | USD ($) | Pending Litigation [Member] | Pending Litigation [Member] | Pending Litigation [Member] | Lehman Matter [Member] | |
USD ($) | Pending Litigation [Member] | USD ($) | USD ($) | USD ($) | Pending Litigation [Member] | ||||
USD ($) | |||||||||
Loss Contingencies [Line Items] | |||||||||
Loss Contingency, Fine | $1,447,000,000 | € 1,060,000,000 | |||||||
Loss Contingency, Pre-Payment Amount For Forward-Purchase Agreement | 1,000,000,000 | ||||||||
Loss Contingency, Cash Collateral Received For Forward-Purchase Agreement | 1,000,000,000 | ||||||||
Loss Contingency, Shares Of Intel Common Stock Required To Be Delivered Under Forward-Purchase Agreement | 50 | ||||||||
Loss Contingency, Cash Collateral Foreclosed On In Forward-Purchase Agreement | 1,000,000,000 | ||||||||
Loss Contingency, Damages Sought, Value | 129,000,000 | 312,000,000 | |||||||
Loss Contingency, Basis Spread On Variable Rate For Damages Sought | 13.50% | ||||||||
Loss Contingency, Range of Possible Loss, Maximum | $129,000,000 | ||||||||
Loss Contingency, Cash Per Share of Acquiree Common Stock and Common Stock Subject to Restricted Stock Awards, Vested Restricted Stock Unit Awards, and Vested Performance Stock Unit Awards Upon Completion of Acquisition | $48 | ||||||||
Loss Contingency, Plaintiffs Damages Expert Value Assertion of Share of Acquiree for Purposes of Assessing Damages | $62.08 |
Operating_Segments_Information2
Operating Segments Information (Detail) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Mar. 28, 2015 | Mar. 29, 2014 |
Schedule Of Segment Reporting Information [Abstract] | ||
Net revenue | $12,781 | $12,764 |
Operating income (loss) | 2,615 | 2,510 |
Client Computing Group [Member] | ||
Schedule Of Segment Reporting Information [Abstract] | ||
Net revenue | 7,420 | 8,097 |
Operating income (loss) | 1,410 | 1,847 |
Data Center Group [Member] | ||
Schedule Of Segment Reporting Information [Abstract] | ||
Net revenue | 3,679 | 3,087 |
Operating income (loss) | 1,701 | 1,336 |
Internet of Things Group [Member] | ||
Schedule Of Segment Reporting Information [Abstract] | ||
Net revenue | 533 | 482 |
Operating income (loss) | 87 | 115 |
Software and services operating segments [Member] | ||
Schedule Of Segment Reporting Information [Abstract] | ||
Net revenue | 534 | 553 |
Operating income (loss) | 3 | 8 |
All other [Member] | ||
Schedule Of Segment Reporting Information [Abstract] | ||
Net revenue | 615 | 545 |
Operating income (loss) | ($586) | ($796) |